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ABSTRACT: Triﬂuoromethyl vinyl sulﬁde, a potential building block for pharmaceutically and agrochemically relevant
products, is prepared and used for the ﬁrst time in high-pressure-mediated 1,3-dipolar cycloaddition reactions with nitrones to
synthesize (triﬂuoromethyl)sulfanyl isoxazolidines.
■ INTRODUCTION
The (triﬂuoromethyl)sulfanyl group (SCF3) represents a
privileged substituent in agrochemicals and pharmaceuticals
because of the strong electron-withdrawing eﬀect and the large
Hansch lipophilicity parameter (π = 1.44).1 Cefazaﬂur,2 a ﬁrst-
generation cephalosporin antibiotic, toltrazuril,3 an antiproto-
zoal agent, and a losartan analogue,4 developed as a potential
hypotensive agent, are prominent examples of biologically active
compounds bearing the SCF3 group (Figure 1).
Hence, CF3S-containing compounds are considered appeal-
ing targets in the agrochemical and pharmaceutical ﬁelds, and
consequently, modern research has focused on eﬃcient
(triﬂuoromethyl)sulfanylation methods. The main strategies
that have been developed to synthesize CF3S-containing
compounds have focused on direct C−S bond formation5 and
triﬂuoromethylation of sulfur-containing compounds.6 How-
ever, incorporation via simple CF3S-containing building blocks
is still unprecedented so that the use of a CF3S-containing
reagent could be an alternative strategy to construct CF3S-
substituted heterocycles. More speciﬁcally, triﬂuoromethyl vinyl
sulﬁde (2) could be an attractive building block to provide
straightforward access to a wide variety of hetero- and
carbocycles via cycloaddition reactions. Previously reported
examples of cycloaddition reactions of alkene 2 are rather scarce:
there is a single example of a Diels−Alder reaction with 2,3-
dimethylbutadiene to yield the corresponding CF3S-cyclo-
hexene,7 and two cyclopropanation examples with organo-
mercury reagents to yield CF3S-substituted cyclopropanes.
8
The potential of this unexplored chemistry and the inherent
biological attractiveness of these molecules motivated us to
further study the reactivity of alkene 2 in cycloaddition
reactions. Thus, we herewith present the study of the ﬁrst 1,3-
dipolar cycloaddition reactions of 2 with several nitrones9 to
synthesize a novel group of isoxazolidines (Scheme 1).
■ RESULTS AND DISCUSSION
We commenced our investigations by forming alkene 2 in situ.
Because of its high volatility,7 we ﬁrst performed the elimination
reactions in deuterated solvents in order to instantly measure
conversions from commercially available chloro alkane 1 into
alkene 2, with no need for further treatment or isolation of the
alkene. We tested several bases (Et3N, DBU, KO
tBu, KOH and
KOTMS) in the presence of various deuterated solvents
(CD2Cl2, THF-d8, CD3OD and DMF-d7; see the Supporting
Information (SI) for experimental details) to eventually choose
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Figure 1. Bioactive heterocycles containing the SCF3 group.
Scheme 1. Synthesis of CF3S-Containing Isoxazolidines
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a solution of KOtBu in THF-d8 at 21 °C for 90 min as the ﬁnal
method for the in situ synthesis of alkene 2 with full conversion.
Initially, we focused on the synthesis of 2,5-disubstituted
isoxazolidines 3 using N-substituted hydroxylamines 5 and
paraformaldehyde as precursors for the in situ synthesis of the
dipoles (Table 1). The nitrone intermediates were used without
isolation in a one-pot process with a preformed solution of
alkene 2 (3 equiv) and In(OTf)3 (0.06 equiv). In this manner,
we obtained isoxazolidine 3a in 22% yield after column
chromatography. Increasing the concentration of 2 (6 equiv)
resulted in a yield of 38% (entry 1). Isoxazolidines 3b−e were
synthesized in yields between 20 and 30% under the same
reaction conditions with diﬀerent substrates (entries 2−5).
However, yields were rather low after column chromatography
in all cases (see the SI for experimental details).
With these results in hand and because of the low yields in the
synthesis of 3a−e, we changed our strategy to the synthesis of
2,3,5-trisubstituted isoxazolidines 4, exhibiting a second
(hetero)aromatic group at the 3-position and introducing
consequently a second chiral center in the molecule (Scheme
2, Table 2).
We ﬁrst performed the reaction with nitrone 6a (R = H), a
catalytic amount of In(OTf)3, and alkene 2 at 21 °C in THF, but
no conversion into the product was observed. When the same
conditions were applied at 80 °C with nitrone 6c (R = Me), less
than 7% conversion into the ﬁnal product was observed by 1H
NMR, presumably because of the low reactivity of this alkene
and perhaps due to its volatility. Therefore, we decided to
perform these reactions under high-pressure conditions (Table
2), which is an established and powerful tool to increase the rate
of cycloaddition reactions.10 Thus, when 1.3 equiv of 2 at 21 °C
under a 15 kbar pressure was used (entry 1) we gratifyingly
observed an 83% conversion into isoxazolidines 4c and 7c
(regioisomeric ratio 4c/7c 13:1, diastereomeric ratio [dr] cis-
4c/trans-4c 7:2). Nitrone 6b gave only 56% conversion under
the same reaction conditions (entry 4), with similar regio- and
diastereoisomeric ratios. When increasing the concentration of
alkene 2, 93 and 75% conversions into compounds 4c and 4b
were obtained, respectively (entries 2 and 5). Finally, an increase
of the temperature to 50 °C gave nearly full conversion into the
desired cis- and trans-products 4c and 4b (entries 3 and 6).
Azoxybenzene11 8 was formed in all reactions as a side
product (Scheme 2) and could not be separated in any case
from trans-4 by column chromatography. Thus, we used
galvinoxyl to prevent the formation of compound 8.12 We
were pleased to see that when using 3 equiv of alkene 2 at 50 °C,
in the presence of 1−3 mol % of galvinoxyl as radical scavenger
(entries 7 and 8), not only full conversion into the desired
product 4b was obtained, but also the formation of the azoxy
compound 8 was fully suppressed.
Furthermore, our reactions gave the exo-products as the major
diastereoisomers (the cis-isomers), showing a 3:1 diastereomeric
ratio (entries 7 and 8). Having these results in hand, the scope of
nitrones in this 1,3-dipolar cycloaddition was examined by
employing the conditions shown in entry 7. We ﬁrst synthesized
a total of 18 nitrones (6a−r) with phenyl (containing both
electron-donating and electron-withdrawing groups at the 2-, 3-,
and 4- positions), heterocyclic and carbamoyl substituents in
excellent yields (see the SI). We then studied the scope of the
1,3-dipolar cycloaddition reactions between alkene 2 and
nitrones 6a−r (Table 3).
As shown in Table 3, high and excellent yields (total yields)
were observed for compounds 4a−c, 4f−i, 4l, and 4n. In
addition, in most of the cases the major product (cis-4) was
separated from the other isomers by column chromatography in
good yields (cis-4a−c, cis-4f−j, cis-4m, and cis-4q). Unfortu-
nately, in a few cases the isomers 4 were obtained as a mixture
that could not be separated (4d,e, 4k,l, and 4n). For compounds
4o and 4p, the trans-4 isomer and the corresponding
regioisomers 7 were present as a mixture.13 The assignment of
the cis- and trans-isomers was performed by 2D NMR studies
(NOESY).
The diastereoselectivity was lower for compounds 4o and 4p,
which contained an indole and a pyrrole substituent,
respectively. In these cases, a mixture of cis- and trans-
diastereoisomers was obtained approximately in a 3:2 ratio. In
Table 1. Synthesis of Isoxazolidines 3a−e
entry compd R yield (%)
1 3a C6H5 38
2 3b 3-CF3C6H4 20
3 3c 3,5-Cl2C6H3 22
4a 3d C6H5CH2 30
5a 3e Cy 23
aEt3N (1.0 equiv) was used.
Scheme 2. Formation of Compounds 4, 7, and 8
Table 2. Optimization Process for the 1,3-Dipolar Cycloaddition Reaction of Nitrones 6 with Alkene 2
entry nitrone R 2 (equiv) T (°C) scavenger cis-4/trans-4 8a (%) conva (yield)b (%)
1 6c 4-MeC6H4 1.3 21 76:22 5 83 (41)
c
2 6c 4-MeC6H4 3 21 79:21 22 93 (−)
3 6c 4-MeC6H4 3 50 76:24 6 96 (85)
c
4 6b 4-FC6H4 1.3 21 79:21 7 56 (35)
c
5 6b 4-FC6H4 3 21 79:21 38 75 (−)
6 6b 4-FC6H4 3 50 77:23 17 91 (79)
c
7 6b 4-FC6H4 3 50 galvinoxyl (3%) 76:24 0 100 (78)
8 6b 4-FC6H4 3 50 galvinoxyl (1%) 76:24 1 100 (−)
aCalculated by integration of the 1H NMR signals of the crude mixtures. bIsolated after column chromatography. ctrans-Isomer contaminated with 7.
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addition, for compounds 4o and 4p, a 7:3 ratio of a mixture cis-7
and trans-7 from the regioisomer 7 was observed. For these two
compounds (4o and 4p), the total yields were signiﬁcantly lower
because of incomplete conversion into the products and
puriﬁcation problems. Finally, when using a nonaromatic
nitrone, the ﬁnal benzyl amide isoxazolidine 4r was synthesized
in 60% yield.
To evaluate the apparent regioselectivity of the cycloaddition,
high-level DFT calculations were carried out at the BP86/
TZ2P14 level, using the ADF program.15 Tetrahydrofuran was
simulated using the COSMO solvation model.16 Thermochem-
ical corrections were computed using the temperature and
pressure under which the experiments were performed (see the
SI for computational details).
We focused on understanding the regioselectivity of the
cycloaddition between a simple model nitrone 9 with alkene 2
(Scheme 3). This reaction proceeds in a concerted and
asynchronous manner with a Gibbs free energy barrier of 21.3
and 24.0 kcal mol−1 for 10 and 11, respectively (Table 4). The
ΔΔG⧧ of 2.7 kcal mol−1 facilitates a high degree of
regioselectivity, resulting in a calculated product ratio of 98:2
for 10/11. Furthermore, the experimentally observed re-
gioisomer 10 is more stable than 11 (ΔΔGrxn = 3.9 kcal
mol−1). The calculated product ratio for the model nitrone
cycloaddition is in line with experimentally observed regiose-
lectivity of reactions involving the majority of the nitrones 6.
Insight into why regioisomer 10 is favored over the other, 11,
is provided by the activation strain model (ASM)17 (also known
as the distortion-interaction model).18 In this framework, the
potential energy surface ΔE(ζ) is decomposed along the
reaction coordinate ζ into the strain ΔEstrain(ζ) associated
with deforming the individual reactants plus the actual
interaction ΔEint(ζ) between the deformed reactants.
ζ ζΔ = Δ + Δ‡E E E( ) ( )strain int (1)
The ΔEint(ζ) between the reactants is further analyzed by an
energy decomposition analysis (EDA) in the conceptual
framework provided by the Kohn−Sham molecular orbital
(KS-MO) model19 and is decomposed into three physically
meaningful terms:
ζ ζ ζ ζΔ = Δ + Δ + ΔE V E E( ) ( ) ( ) ( )int elstat Pauli oi (2)
The ΔVelstat(ζ) term corresponds to the classical electrostatic
interaction between unperturbed charge distributions,
ΔEPauli(ζ) is responsible for any steric repulsion, and the
ΔEoi(ζ) accounts for charge transfer (HOMO−LUMO
interactions) and polarization.
Applying the ASM along the reaction coordinate deﬁned by
the bending of the 1,3-dipole, it is revealed that reactivity
Table 3. Scope of the High-Pressure-Promoted 1,3-Dipolar Cycloaddition Reaction
aCombined yield. bCalculated by 1H NMR of the crude. cGalvinoxyl was not used in the reaction. dcis-4o,p/trans-4o,p/(mixture of isomers 7).
Scheme 3. Formation of Compounds 10 and 11
Table 4. Computed Activation Barriers, Reaction Energies
(kcal mol−1), and Product Distribution Computed at the
COSMO(THF)-BP86/TZ2P Level of Theory
compd ΔE⧧ (ΔG⧧) ΔErxn (ΔGrxn) product ratioa
10 12.8 (21.3) −17.6 (−6.1) 98
11 15.0 (24.0) −14.3 (−2.2) 2
aCalculated at 50 °C and 15 kbar based on the ΔΔG⧧ between 10 and
11 (see the SI for details).
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diﬀerences in the reaction between 9 and 2 leading to 10 (blue
curve) and 11 (red curve) are a result of ΔEint (Figure 2a).
ΔEstrain remains nearly constant for both reactions along the
reaction coordinate. Next, the EDA terms were analyzed, and
the ΔEPauli dominates and is chieﬂy responsible for the
diﬀerence in the interaction energies (Figure 2b). The more
favorable ΔVelstat and ΔEoi curves associated with the reaction
leading to 11 are unable to overcome for increased steric
repulsion associated with this approach. These results highlight
the fact that the reaction results from the least hindered
approach, leaving the SCF3 group far away from the CH2 group.
See the SI for an ASA and EDA analysis on 6m and 6p.
In summary, we have developed the synthesis of a new class of
5-[(triﬂuoromethyl)sulfanyl]isoxazolidines. The reactions uti-
lized for their synthesis were high-pressure-promoted 1,3-
dipolar cycloaddition reactions between triﬂuoromethyl vinyl
sulﬁde 2 and various easily synthesized nitrones. The results of
our DFT computations are in harmony with experimental
results and were leveraged to show that the high regioselectivity
of these cycloaddition reactions originates from minimizing
steric repulsion.
■ EXPERIMENTAL SECTION
General Information. Reagents were obtained from commercial
suppliers and were used without puriﬁcation. Standard syringe
techniques were applied for the transfer of dry solvents and air- or
moisture-sensitive reagents. Tetrahydrofuran was used as a solvent after
distillation. Potassium tert-butoxide was used as a 1.0 M solution in
tetrahydrofuran. The high-pressure experiments were run in a high-
pressure apparatus equipped with a one-wall-piston cylinder for
pressures up to 15 kbar (1.5 GPa). Reactions were performed in 1−
1.5 mL PTFE ampules closed by screwed stainless steel stoppers. These
ampules were inserted into the high-pressure vessel ﬁlled with 80−100
petroleum ether as transmission medium. Reactions were followed, and
Rf values were obtained, using thin layer chromatography (TLC) on
silica gel-coated plates (Merck 60 F254) with the indicated solvent
mixture. Detection was performed with UV light, and/or by charring at
ca. 150 °C after dipping into a solution of KMnO4. Infrared spectra
were recorded on an IR-ATR Bruker TENSOR 27 spectrometer. High-
resolution mass spectra were recorded on a JEOL AccuTOF (ESI) or a
MAT900 (EI, CI, and ESI) GC-TOF. NMR spectra were recorded at
298 K on a Varian Inova 400 (400 MHz), Bruker Avance III 400 MHz
or Bruker Avance III 500 MHz spectrometer in the solvent indicated.
Chemical shifts are given in parts per million (ppm) with respect to
tetramethylsilane (0.00 ppm) as internal standard for 1H NMR; and
CDCl3 (77.16 ppm) as internal standard for
13C NMR. Coupling
constants are reported as J values in hertz (Hz). 1H NMR data are
reported as follows: chemical shift (ppm), multiplicity (s = singlet, d =
doublet, dd = doublet of doublets, dt = doublet of triplets, dtdq =
doublet of triplet of doublet of quartets, dq = doublet of quartets, ddd =
doublet of doublet of doublets, ddt = doublet of doublets of triplets,
dddd= doublet of doublets of doublets of doublets, ddquint = doublet
of doublet of quintets, dddquint = doublet of doublet of doublet of
quintets, quint = quintet, t = triplet, td = triplet of doublets, tt = triplet
of triplets m = multiplet, b = broad), coupling constants (Hz),
integration and assignment. Compounds were fully characterized by
1H, 13C, 2D gDQCOSY, gHSQC, gHMBC, NOESY, and HOESY
spectra. The characterization and assignment of isoxazolidines 4a−r
were done either from isolated compounds or mixtures of isomers.
Column or ﬂash chromatography was carried out using ACROS silica
gel (0.035−0.070 mm, and 60 Å pore diameter).
General Procedure for the Synthesis of Triﬂuoromethyl Vinyl
Sulﬁde 2. 2-Chloroethyl triﬂuoromethyl sulﬁde (1.0 equiv) was
dissolved in distilled THF (0.40 M) under inert atmosphere and cooled
to 0 °C. Then, KOtBu (1.0 equiv, 1.0 M solution in THF) was added
slowly, and the mixture was warmed to 21 °C for 90 min. This solution
was used for the cycloaddition reactions of alkene 2. 1H NMR [400
MHz, δ (ppm), THF-d8]: 6.54 (dd, J = 16.5, 9.4 Hz, 1 H), 5.75−5.66
(m, 2 H). 13C NMR [101 MHz, δ (ppm), THF-d8]: 129.8 (q, J = 306.5
Hz), 124.4 (q, J = 1.0 Hz), 121.3 (q, J = 3.2 Hz). 19F NMR [377 MHz, δ
(ppm), THF-d8]: −43.6.7
General Procedure for the Synthesis of Hydroxylamines 5b
and 5c. The corresponding nitrobenzene (12b or 12c; 1 equiv) was
added to a ﬂame-dried Schlenk tube containing a suspension of Pd/C
(0.25 equiv) in dry THF (10 mL). The mixture was cooled to 0 °C, and
N2H4·H2O (2.0 equiv) was added dropwise. The reaction was carefully
monitored by TLC until the starting material disappeared. The crude
mixture was diluted with THF (10 mL) and ﬁltered over a pad of
diatomaceous earth. The solvent was evaporated in vacuo, and the
crude mixture was puriﬁed by column chromatography using CH2Cl2
under a nitrogen atmosphere.
N-[3-(Triﬂuoromethyl)phenyl]hydroxylamine (5b). According to
general procedure, the reaction of 1-nitro-3-(triﬂuoromethyl)benzene
12b (1.0 g, 5.23 mmol) aﬀorded hydroxylamine 5b (885 mg, 5.00
mmol) as a pale yellow oil. 1H NMR [400 MHz, δ (ppm), CDCl3]:
7.41−7.34 (m, 1 H), 7.28−7.26 (m, 1 H), 7.23−7.19 (m, 1 H), 7.15−
7.10 (m, 1 H), 6.74−4.98 (bs, 2 H). Rf: 0.31 (CH2Cl2). Yield: 95%.
NMR spectral data are in accordance with previously reported data.20
N-(3,5-Dichlorophenyl)hydroxylamine (5c). According to general
procedure, the reaction of 1,3-dichloro-5-nitrobenzene 12c (1.0 g, 5.22
mmol) aﬀorded hydroxylamine 5c (827 mg, 4.65 mmol) as a yellow
solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 6.93 (t, J = 1.8 Hz, 1 H),
6.88 (d, J = 1.8 Hz, 2 H), 6.79 (bs, 1 H), 5.31 (bs, 1 H). Rf: 0.33
(CH2Cl2). Yield: 89%. NMR spectral data are in accordance with
previously reported data.20
General Procedure for the Synthesis of Isoxazolidines 3a−c.
A solution of the corresponding hydroxylamine 5 (1 equiv) in THF
(0.22 M) was added to a solution of paraformaldehyde (3 equiv) in
THF (0.22 M) at 0 °C. Then a cooled solution (0 °C) of alkene 2 (6.0
equiv) was subsequently added to the solution containing paraformal-
dehyde and the hydroxylamine. Finally, a solution of In(OTf)3 (0.06
equiv) in dry THF (44 mM) was added to the reaction mixture. The
reaction mixture was warmed to 21 °C and stirred for 16 h. Then, the
reaction mixture was quenched with a saturated aqueous solution of
NaHCO3 (10 mL), and the aqueous layer was extracted with AcOEt (2
× 10 mL). The combined organic layers were dried over MgSO4,
ﬁltered oﬀ and concentrated in vacuo. The crude mixture was puriﬁed
by column chromatography using the indicated eluent to aﬀord
isoxazolines 3a−c.
2-Phenyl-5-[(triﬂuoromethyl)sufanyl]isoxazolidine (3a). Accord-
ing to the general procedure, the reaction of N-phenylhydroxylamine
5a (17.8 mg, 0.163 mmol) aﬀorded isoxazolidine 3a (15.3 mg, 0.163
mmol) as a brown solid after column chromatography (heptane/
AcOEt, 19:1 → 4:1). 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.34−
Figure 2. (a) Activation strain and (b) energy decomposition analyses
of the cycloaddition reactions of nitrone 9 with alkene 2 up to their
respective TS (indicated by the dot) computed at the BP86/TZ2P
level.
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7.27 (m, 2 H), 7.08−7.05 (m, 2 H), 7.03 (tt, J = 7.3, 1.1 Hz, 1 H), 5.98
(dd, J = 8.1, 4.3 Hz, 1 H), 3.85−3.71 (m, 1 H), 3.24 (ddd, J = 9.3, 8.2,
7.6 Hz, 1 H), 2.91 (dtdq, J = 13.2, 8.2, 4.0, 0.8 Hz, 1 H), 2.48−2.28 (m,
1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 149.8, 130.1 (q, J =
307.7 Hz), 129.0, 123.0, 116.1, 81.1 (q, J = 2.2 Hz), 52.0, 36.0 (q, J = 1.1
Hz). 19F NMR [471 MHz, δ (ppm), CDCl3]: −39.8. FTIR [ν̅ (cm−1)]:
2860, 1599, 1491, 1295, 1109, 752, 692. HRMS (EI) m/z: [M+•] calcd
for C10H10F3NOS 249.0435, found 249.0458. Rf: 0.56 (heptane/
AcOEt, 4:1). Yield: 38%.
2-[3-(Triﬂuoromethyl)phenyl]-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (3b). According to the general procedure, the reaction of
hydroxylamine 5b (56.2 mg, 0.318 mmol) aﬀorded isoxazolidine 3b
(23.5 mg, 0.071 mmol) as a colorless oil, after column chromatography
(heptane/AcOEt/Et3N, 12.2:1:0.13).
1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.41 (ddquint, J = 8.2, 7.2, 0.8 Hz, 1 H), 7.29−7.25 (m, 2 H),
7.23−7.19 (m, 1 H), 6.01 (dd, J = 8.0, 4.2 Hz, 1 H), 3.83 (ddd, J = 9.1,
8.2, 4.3 Hz, 1 H), 3.30 (ddd, J = 9.1, 8.5, 7.4 Hz, 1 H), 3.02−2.90 (m, 1
H), 2.48−2.38 (m, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]:
150.1, 131.3 (q, J = 32.3 Hz), 129.8 (q, J = 307.9 Hz), 129.4, 124.0 (q, J
= 272.4 Hz), 119.2 (q, J = 3.8 Hz), 118.9, 112.3 (q, J = 4.0 Hz), 81.1 (q,
J = 2.4 Hz), 51.7, 35.8 (q, J = 1.2 Hz). 19F NMR [471 MHz, δ (ppm),
CDCl3]: −39.9, −62.8. FTIR [ν̅ (cm−1)]: 2956, 2925, 2855, 1593,
1328, 1120, 795, 698. HRMS (EI) m/z: [M+•] calcd for C11H9F6NOS
317.0309, found 317.0325. Rf: 0.44 (heptane/AcOEt, 4:1). Yield: 22%.
2-(3,5-Dichlorophenyl)-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine
(3c). According to the general procedure, the reaction of hydroxylamine
5c (29.3 mg, 0.166 mmol) aﬀorded isoxazolidine 3c (10.33 mg, 0.033
mmol) as a green oil after column chromatography (heptane/AcOEt/
Et3N, 12.2:1:0.13).
1H NMR [500 MHz, δ (ppm), CDCl3]: 6.99 (t, J =
1.8 Hz, 1 H), 6.91 (d, J = 1.8 Hz, 2 H), 5.98 (dd, J = 8.0, 4.1 Hz, 1 H),
3.75 (ddd, J = 8.9, 8.1, 4.4 Hz, 1 H), 3.27 (ddd, J = 9.2, 8.6, 7.1 Hz, 1
H), 3.01−2.87 (m, 1 H), 2.47−2.36 (m, 1 H). 13C NMR [126 MHz, δ
(ppm), CDCl3]: 151.6, 135.4, 129.7 (q, J = 307.9 Hz), 122.5, 114.2,
81.2 (q, J = 2.6 Hz), 51.6, 35.8 (q, J = 1.1 Hz). FTIR [ν ̅ (cm−1)]: 2924,
2850, 1587, 1260, 1115, 1051, 796. HRMS (EI) m/z: [M+•] calcd for
C10H8Cl2F3NOS 316.9656, found 316.9657. Rf: 0.45 (heptane/AcOEt,
4:1). Yield: 20%.
General Procedure for the Synthesis of Isoxazolidines 3d
and 3e. A solution of hydroxylamine hydrochloride 5d or 5e (1 equiv)
in THF (0.22 M) and Et3N (1 equiv) was added to a solution of
paraformaldehyde (3 equiv) in THF (0.22 M) at 0 °C. Then a cooled
solution (0 °C) of alkene 2 (6.0 equiv) was subsequently added to the
solution containing paraformaldehyde and the hydroxylamine. Finally,
a solution of In(OTf)3 (0.06 equiv) in dry THF (22 mM) was added to
the reaction mixture. The reaction mixture was warmed to 21 °C and
stirred for 16 h. Then, the reaction mixture was quenched with a
saturated aqueous solution of NaHCO3 (10 mL), and the aqueous layer
was extracted with AcOEt (2 × 10 mL). The combined organic layers
were dried over MgSO4, ﬁltered oﬀ, and concentrated in vacuo. The
crude mixture was puriﬁed by column chromatography using the
indicated eluent to aﬀord isoxazolines 3d and 3e.
2-Benzyl-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine (3d). Accord-
ing to the general procedure, the reaction of hydroxylamine
hydrochloride 5d (26.8 mg, 0.169 mmol) aﬀorded isoxazolidine 3d
(13.2 mg, 0.050 mmol) as a colorless oil after column chromatography
(heptane/AcOEt/Et3N, 9:1:0.1).
1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.40−7.36 (m, 2 H), 7.35−7.30 (m, 2 H), 7.30−7.27 (m, 1
H), 5.86 (dd, J = 8.3, 4.4 Hz, 1 H), 4.35−3.82 (m, 2 H), 3.34−3.11 (m,
1 H), 3.11−2.40 (m, 1 H), 2.83 (dtd, J = 11.9, 8.0, 3.3 Hz, 1 H), 2.40−
2.18 (m, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 136.2, 130.3 (q,
J = 307.9 Hz), 128.9, 128.4, 127.5, 81.3 (q, J = 2.4 Hz), 61.7, 53.3, 36.5.
19F NMR [471 MHz, δ (ppm), CDCl3]: −39.9. FTIR [ν̅ (cm−1)]:
2849, 1606, 1497, 1455, 1117, 755, 698. HRMS (EI) m/z: [M+•] calcd
for C11H12F3NOS 263.0592, found 263.0604. Rf: 0.41 (heptane/
AcOEt, 4:1). Yield: 30%.
2-Cyclohexyl-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine (3e). Ac-
cording to the general procedure, the reaction of hydroxylamine
hydrochloride 5e (23.1 mg, 0.152 mmol) aﬀorded isoxazolidine 3e
(20.4 mg, 0.080 mmol) as a colorless oil, after column chromatography
(heptane/AcOEt, 19:1→ 5:1). 1H NMR [400 MHz, δ (ppm), CDCl3]:
5.82 (dd, J = 8.1, 4.2 Hz, 1 H), 3.43−3.13 (m, 1 H), 2.85−2.73 (m, 1
H), 2.68−2.50 (m, 1 H), 2.68−2.18 (m, 1 H), 2.31−2.18 (m, 1 H),
1.83−1.69 (m, 2 H), 1.66−1.52 (m, 2 H), 1.39−1.13 (m, 6 H). 13C
NMR [101 MHz, δ (ppm), CDCl3]: 130.4 (q, J = 308.1 Hz), 80.8 (q, J
= 2.2 Hz), 65.8, 51.5, 36.6, 26.0, 24.8, 24.4. 19F NMR [377 MHz, δ
(ppm), CDCl3]: −40.0. FTIR [ν ̅ (cm−1)]: 2924, 2854, 1728, 1455,
1258, 1082, 1009, 788. Rf: 0.44 (heptane/AcOEt, 9:1). Yield: 53%.
General Procedure A for the Syntheses of Nitrones 6d−g, 6i,
6j, 6l−r. The corresponding aldehyde (1.0 equiv, dissolved in 1.5 mL
of dry EtOH for solid compounds) was added to a solution of N-
phenylhydroxylamine (1.05 equiv) in dry EtOH (1.0 mL) at 21 °C
under a nitrogen atmosphere. The reaction mixture was stirred for 16−
21 h, and then the solvent was removed under vacuo. The crude
mixture was puriﬁed by column chromatography using the indicated
eluent to aﬀord nitrones 6d−g, 6i, 6j, 6l−r.
General Procedure B for the Syntheses of Nitrones 6a−c, 6h,
and 6k. The corresponding aldehyde (1.0 equiv) was added to a
solution of N-phenylhydroxylamine (1.0 equiv) in dry EtOH (1.0 mL),
and the ﬂask was wrapped with aluminum foil. The reaction mixture
was stirred at 21 °C for 16−21 h, and then the solvent was removed
under vacuo. The crude mixture was puriﬁed by column chromatog-
raphy using the indicated eluent to aﬀord nitrones 6a−c, 6h, and 6k.
(Z)-N,1-Diphenylmethanimine Oxide (6a).21 According to general
procedure B, the reaction of benzaldehyde (47.0 μL, 0.458 mmol) with
N-phenylhydroxylamine (50 mg, 0.458 mmol) aﬀorded nitrone 6a (71
mg, 0.360 mmol) as a white solid, after column chromatography
(heptane/AcOEt, 5:1→ 1:1). 1H NMR [400 MHz, δ (ppm), CDCl3]:
8.44−8.36 (m, 2 H), 7.92 (s, 1 H), 7.81−7.74 (m, 2 H), 7.53−7.43 (m,
6 H). Yield: 79%.
(Z)-1-(4-Fluorophenyl)-N-phenylmethanimine Oxide (6b).22 Ac-
cording to general procedure B, the reaction of 4-ﬂuorobenzaldehyde
(98.0 μL, 0.916 mmol) with N-phenylhydroxylamine (100 mg, 0.916
mmol) aﬀorded nitrone 6b (178.5 mg, 0.829 mmol) as a white solid. 1H
NMR [400 MHz, δ (ppm), CDCl3]: 8.49−8.42 (m, 2 H), 7.91 (s, 1 H),
7.80−7.75 (m, 2 H), 7.55−7.44 (m, 3 H), 7.23−7.14 (m, 2 H). Yield:
91%.
(Z)-N-Phenyl-1-(4-tolyl)methanimine Oxide (6c).22 According to
general procedure B, the reaction of 4-methylbenzaldehyde (163.0 μL,
1.375 mmol) with N-phenylhydroxylamine (127 mg, 1.375 mmol)
aﬀorded nitrone 6c (267.2 mg, 1.26 mmol) as yellow crystals, after
column chromatography (heptane/AcOEt, 5:1→ 1:1). 1H NMR [400
MHz, δ (ppm), CDCl3]: 8.34−8.27 (m, 2 H), 7.89 (s, 1 H), 7.81−7.75
(m, 2 H), 7.51−7.43 (m, 3 H), 7.33−7.28 (m, 2 H), 2.42 (s, 3 H).
Yield: 92%.
(Z)-N-Phenyl-1-[4-(triﬂuoromethyl)phenyl]methanimine oxide
(6d).23 According to general procedure A, the reaction of 4-
(triﬂuoromethyl)benzaldehyde (91 mg, 0.523 mmol) with N-phenyl-
hydroxylamine (60 mg, 0.549 mmol) aﬀorded nitrone 6d (139 mg,
0.523 mmol) as a yellow solid. 1H NMR [400 MHz, δ (ppm), CDCl3]:
8.54−8.48 (m, 2 H), 8.00 (s, 1 H), 7.83−7.76 (m, 2 H), 7.76−7.70 (m,
2 H), 7.55−7.47 (m, 3 H). Yield: 99%.
(Z)-1-[4-(Pentaﬂuoro-λ6-sulfanyl)phenyl]-N-phenylmethanimine
Oxide (6e). According to general procedure A, the reaction of 4-
(pentaﬂuoro-λ6-sulfanyl)benzaldehyde (120 mg, 0.517 mmol) with N-
phenylhydroxylamine (59 mg, 0.543 mmol) aﬀorded nitrone 6e (163.3
mg, 0.505 mmol) as a white-yellow solid. 1H NMR [400 MHz, δ
(ppm), CDCl3]: 8.52−8.45 (m, 2 H), 8.00 (s, 1 H), 7.89−7.81 (m, 2
H), 7.81−7.74 (m, 2 H), 7.58−7.46 (m, 3 H). 13C NMR [101 MHz, δ
(ppm), CDCl3]: 154.5, 149.1, 133.6, 132.5, 130.7, 129.5, 128.9, 126.5
(quint, J = 4.4 Hz), 121.9. FTIR [ν̅ (cm−1)]: 3057, 1594, 1573, 1074,
821, 810, 765. HRMS (ESI-TOF) m/z: [M + H]+ calcd for
C13H11F5NOS 324.0476, found 324.0482. Rf: 0.45 (CH2Cl2). Yield:
98%.
(Z)-1-(4-Methoxyphenyl)-N-phenylmethanimine oxide (6f).24 Ac-
cording to general procedure A, the reaction of 4-methoxybenzalde-
hyde (0.063 mL, 0.514 mmol) with N-phenylhydroxylamine (59 mg,
0.540 mmol) aﬀorded nitrone 6f (110 mg, 0.484 mmol) as a yellow-
brown solid, after column chromatography (CH2Cl2 → CH2Cl2/
MeOH, 10:0.2). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.44−8.36
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(m, 2 H), 7.84 (s, 1 H), 7.79−7.72 (m, 2 H), 7.50−7.37 (m, 3 H),
7.01−6.93 (m, 2 H), 3.86 (s, 3 H). Yield: 94%.
(Z)-1-(3-Fluorophenyl)-N-phenylmethanimine Oxide (6g).25 Ac-
cording to general procedure A, the reaction of 3-ﬂuorobenzaldehyde
(0.060 mL, 0.564 mmol) with N-phenylhydroxylamine (62 mg, 0.564
mmol) aﬀorded nitrone 6g (118 mg, 0.548 mmol) as a light brown
solid, after column chromatography (heptane/CH2Cl2, 1:4→ CH2Cl2/
MeOH, 10:1). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.44 (ddd, J =
10.6, 2.6, 1.6 Hz, 1 H), 7.94 (s, 1 H), 7.90 (ddt, J = 8.1, 1.6, 0.7 Hz, 1
H), 7.80−7.73 (m, 2 H), 7.54−7.47 (m, 3 H), 7.44 (td, J = 8.1, 5.9 Hz,
1 H), 7.17 (tdd, J = 8.1, 2.6, 1.0 Hz, 1 H). 13C NMR [101 MHz, δ
(ppm), CDCl3]: 162.8 (d, J = 245.5 Hz), 149.1, 133.5, 132.6 (d, J = 9.1
Hz), 130.4, 130.1 (d, J = 8.4 Hz), 129.4, 125.1 (d, J = 3.0 Hz), 121.8,
118.0 (d, J = 21.7 Hz), 115.3 (d, J = 24.7 Hz). Yield: 97%.
(Z)-N-Phenyl-1-(3-tolyl)methanimine Oxide (6h).25 According to
general procedure B, the reaction of 3-methylbenzaldehyde (42 μL,
0.458 mmol) with N-phenylhydroxylamine (50 mg, 0.458 mmol)
aﬀorded nitrone 6h (95.3 mg, 0.451 mmol) as a yellow oil, after column
chromatography (heptane/AcOEt, 5:1→ 1:1). 1H NMR [400 MHz, δ
(ppm), CDCl3]: 8.32 (tq, J = 1.8, 0.7 Hz, 1 H), 8.12 (dddquint, J = 7.8,
1.8, 1.2, 0.7 Hz, 1 H), 7.89 (s, 1 H), 7.81−7.75 (m, 2 H), 7.53−7.44 (m,
3 H), 7.38 (t, J = 7.8 Hz, 1 H), 7.32−7.27 (m, 1 H), 2.43 (s, 3 H). 13C
NMR [101 MHz, δ (ppm), CDCl3]: 149.3, 138.5, 134.9, 132.0, 130.8,
130.0, 129.4, 129.3, 128.7, 126.6, 121.9, 21.6. FTIR [ν̅ (cm−1)]: 3092,
2963, 2920, 1652, 1590, 1459, 1088, 781, 692. HRMS (ESI-TOF) m/z:
[M + H]+ calcd for C14H14NO 212.1070, found 212.1085. Yield: 98%.
(Z)-1-[3-(Methoxycarbonyl)phenyl]-N-phenylmethanimine Oxide
(6i). According to general procedure A, the reaction of methyl 3-
formylbenzoate (90 mg, 0.548 mmol) with N-phenylhydroxylamine
(63 mg, 0.576 mmol) aﬀorded nitrone 6i (112 mg, 0.439 mmol) as a
yellow oil, after column chromatography (CH2Cl2→ CH2Cl2/MeOH,
10:1). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.88 (dddd, J = 7.9, 1.7,
1.2, 0.5 Hz, 1 H), 8.80 (tt, J = 1.7, 0.5 Hz, 1 H), 8.13 (ddd, J = 7.9, 1.7,
1.2 Hz, 1 H), 8.01 (d, J = 0.5 Hz, 1 H), 7.83−7.75 (m, 2 H), 7.59 (tt, J =
7.9, 0.5 Hz, 1 H), 7.54−7.46 (m, 3 H), 3.95 (s, 3 H). 13C NMR [101
MHz, δ (ppm), CDCl3]: 166.5, 149.0, 133.6, 132.6, 131.6, 131.0, 130.6,
130.4, 130.2, 129.3, 129.0, 121.7, 52.4. FTIR [ν ̅ (cm−1)]: 3064, 2952,
1718, 1434, 1278, 1187, 1072, 912, 729, 684. HRMS (ESI-TOF) m/z:
[M + H]+ calcd for C15H14NO3 256.0968, found 256.0984. Rf: 0.07
(CH2Cl2). Yield: 80%.
(Z)-1-(3-Methoxyphenyl)-N-phenylmethanimine Oxide (6j). Ac-
cording to general procedure A, the reaction of 3-methoxybenzalde-
hyde (0.063 mL, 0.514 mmol) with N-phenylhydroxylamine (59 mg,
0.540 mmol) aﬀorded nitrone 6j (115 mg, 0.506 mmol) as a yellow oil,
after column chromatography (CH2Cl2 → CH2Cl2/MeOH, 10:0.2).
1H NMR [400 MHz, δ (ppm), CDCl3]: 8.38 (dd, J = 2.7, 1.5 Hz, 1 H),
7.92 (s, 1 H), 7.81−7.75 (m, 2 H), 7.66 (dddd, J = 7.7, 1.5, 1.0, 0.5 Hz,
1 H), 7.52−7.44 (m, 3 H), 7.38 (dd, J = 8.3, 7.7 Hz, 1 H), 7.05 (ddd, J =
8.3, 2.7, 1.0 Hz, 1 H), 3.89 (s, 3 H). 13C NMR [101 MHz, δ (ppm),
CDCl3]: 159.7, 149.1, 134.7, 131.9, 130.0, 129.5, 129.2, 122.3, 121.8,
118.1, 112.7, 55.4. FTIR [ν̅ (cm−1)]: 3060, 2834, 1553, 1270, 1025,
769, 684. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C14H13NO2Na
250.0839, found 250.0857. Rf: 0.06 (CH2Cl2). Yield: 98%.
(Z)-N-Phenyl-1-[3-(triﬂuoromethyl)phenyl]methanimine Oxide
(6k).25 According to general procedure B, the reaction of 3-
(triﬂuoromethyl)benzaldehyde (61 μL, 0.458 mmol) with N-phenyl-
hydroxylamine (50 mg, 0.458 mmol) aﬀorded nitrone 6k (116 mg,
0.437 mmol) as a white solid, after column chromatography (heptane/
AcOEt, 5:1→ 1:1). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.70 (dq, J
= 2.3, 1.0 Hz, 1 H), 8.59 (dddd, J = 7.9, 1.7, 1.2, 0.6 Hz, 1 H), 8.01 (s, 1
H), 7.84−7.75 (m, 2 H), 7.72 (dq, J = 8.5, 1.1 Hz, 1 H), 7.61 (t, J = 7.9
Hz, 1 H), 7.55−7.48 (m, 3 H). 13C NMR [101 MHz, δ (ppm), CDCl3]:
149.1, 133.1, 131.8 (q, J = 1.0 Hz), 131.5, 131.5, 130.5, 129.5, 129.3,
127.3 (q, J = 3.7 Hz), 125.7 (q, J = 3.9 Hz), 122.6, 121.9. FTIR [ν̅
(cm−1)]: 3124, 1604, 1330, 1120, 1068, 770, 692. HRMS (ESI-TOF)
m/z: [M + H]+ calcd for C14H11F3NO 266.0787, found 266.0799. Rf:
0.35 (CH2Cl2). Yield: 95%.
(Z)-N-Phenyl-1-(2-tolyl)methanimine Oxide (6l).26 According to
general procedure A, the reaction of 2-methylbenzaldehyde (0.061 mL,
0.524 mmol) with N-phenylhydroxylamine (60 mg, 0.551 mmol)
aﬀorded nitrone 6l (107 mg, 0.508 mmol) as a yellow-brown solid, after
column chromatography (CH2Cl2 → CH2Cl2/MeOH, 10:0.2).
1H
NMR [400 MHz, δ (ppm), CDCl3]: 9.42−9.32 (m, 1 H), 8.07 (s, 1 H),
7.81−7.73 (m, 2 H), 7.53−7.44 (m, 3 H), 7.39−7.33 (m, 2 H), 7.28−
7.23 (m, 1 H), 2.46 (s, 3 H). Yield: 97%.
(Z)-1-(2-Methoxyphenyl)-N-phenylmethanimine Oxide (6m).25
According to general procedure A, the reaction of 2-methoxybenzalde-
hyde (70 mg, 0.514 mmol) withN-phenylhydroxylamine (59 mg, 0.540
mmol) aﬀorded nitrone 6m (106 mg, 0.464 mmol) as an orange-brown
solid, after column chromatography (CH2Cl2 → CH2Cl2/MeOH,
10:0.2). 1H NMR [400 MHz, δ (ppm), CDCl3]: 9.48 (dd, J = 7.9, 1.7
Hz, 1 H), 8.40 (s, 1 H), 7.85−7.73 (m, 2 H), 7.53−7.39 (m, 4 H),
7.13−7.06 (m, 1 H), 6.93 (dd, J = 8.4, 1.1 Hz, 1 H), 3.89 (s, 3 H). 13C
NMR [101 MHz, δ (ppm), CDCl3]: 157.6, 149.8, 132.3, 129.8, 129.4,
129.2, 128.9, 122.0, 121.0, 120.1, 110.0, 55.8. FTIR [ν̅ (cm−1)]: 3058,
1577, 1288, 1046, 746, 691, 611. Rf: 0.07 (CH2Cl2). Yield: 90%.
(Z)-N-Phenyl-1-(thiophen-3-yl)methanimine Oxide (6n).27 Ac-
cording to general procedure A, the reaction of thiophene-3-
carbaldehyde (0.047 mL, 0.535 mmol) with N-phenylhydroxylamine
(61 mg, 0.562 mmol) aﬀorded nitrone 6n (109 mg, 0.535 mmol) as a
white-yellow solid, after column chromatography (heptane/CH2Cl2,
1:1→ heptane/CH2Cl2, 0:1).
1H NMR [400 MHz, δ (ppm), CDCl3]:
9.16 (ddd, J = 3.1, 1.2, 0.7 Hz, 1 H), 8.06 (d, J = 0.6 Hz, 1 H), 7.82−
7.76 (m, 2 H), 7.52−7.46 (m, 3 H), 7.45 (dd, J = 5.2, 1.2 Hz, 1 H), 7.39
(dd, J = 5.1, 3.0 Hz, 1 H). Yield: 99%.
(Z)-1-(1H-Indol-2-yl)-N-phenylmethanimine Oxide (6o). Accord-
ing to general procedure A, the reaction of 1H-indole-2-carbaldehyde
(80 mg, 0.551 mmol) with N-phenylhydroxylamine (63 mg, 0.579
mmol) aﬀorded nitrone 6o (130 mg, 0.551 mmol) as a yellow-brown
solid. 1H NMR [500 MHz, δ (ppm), CDCl3]: 11.69 (s, 1 H), 8.14 (s, 1
H), 7.87−7.80 (m, 2 H), 7.67 (dd, J = 8.1, 1.0 Hz, 1 H), 7.55−7.45 (m,
4 H), 7.32 (ddd, J = 8.2, 6.9, 1.1 Hz, 1 H), 7.16 (ddd, J = 8.0, 6.9, 1.0
Hz, 1 H), 6.94 (s, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 147.4,
136.0, 130.2, 129.9, 129.4, 127.6, 126.8, 125.2, 121.3, 120.8, 112.3,
108.6. FTIR [ν ̅ (cm−1)]: 3315, 3067, 1593, 1502, 1345, 1234, 818, 733.
HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C15H12N2ONa 259.0842,
found 259.0858. Rf: 0.13 (CH2Cl2). Yield: 99%.
(Z)-N-Phenyl-1-(1H-pyrrol-2-yl)methanimine Oxide (6p). Accord-
ing to general procedure A, the reaction of 1H-pyrrole-2-carbaldehyde
(52 mg, 0.547 mmol) with N-phenylhydroxylamine (60 mg, 0.550
mmol) aﬀorded nitrone 6p (62 mg, 0.333 mmol) as a dark brown solid,
after column chromatography (CH2Cl2 → CH2Cl2/MeOH, 10:0.1).
1H NMR [500 MHz, δ (ppm), CDCl3]: 12.21 (s, 1 H), 7.95 (s, 1 H),
7.81−7.73 (m, 2 H), 7.52−7.38 (m, 3 H), 7.07 (td, J = 2.7, 1.3 Hz, 1
H), 6.70 (dt, J = 3.6, 1.6 Hz, 1 H), 6.40 (dt, J = 3.9, 2.5 Hz, 1 H). 13C
NMR [126 MHz, δ (ppm), CDCl3]: 147.1, 129.5, 129.3, 126.1, 125.3,
121.3, 121.0, 115.9, 111.3. FTIR [ν̅ (cm−1)]: 3317, 3062, 1580, 1403,
1294, 1074, 1045, 740, 686. HRMS (ESI-TOF) m/z: [M + H]+ calcd
for C11H11N2O 187.0866, found 187.0885. Rf: 0.45 (heptane/AcOEt,
1:1). Yield: 61%.
(Z)-1-(Furan-2-yl)-N-phenylmethanimine Oxide (6q).28 According
to general procedure A, the reaction of furan-2-carbaldehyde (0.043
mL, 0.520 mmol) with N-phenylhydroxylamine (60 mg, 0.546 mmol)
aﬀorded nitrone 6q (97 mg, 0.520 mmol) as a light brown solid, after
column chromatography (CH2Cl2 → CH2Cl2/MeOH, 10:0.2).
1H
NMR [400 MHz, δ (ppm), CDCl3]: 8.16 (s, 1 H), 8.01 (dt, J = 3.5, 0.7
Hz, 1 H), 7.83−7.77 (m, 2 H), 7.58 (dd, J = 1.8, 0.7 Hz, 1 H), 7.52−
7.44 (m, 3 H), 6.65 (dd, J = 3.6, 1.8 Hz, 1 H). Yield: 99%.
(Z)-2-(Benzylamino)-2-oxo-N-phenylethan-1-imine Oxide (6r).
According to general procedure A, the reaction of N-benzyl-2-
oxoacetamide (56 mg, 0.343 mmol) with N-phenylhydroxylamine
(26 mg, 0.240 mmol) aﬀorded nitrone 6r (34.5 mg, 0.135 mmol) as a
white solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 10.39 (s, 1 H),
7.72−7.67 (m, 2 H), 7.66 (s, 1 H), 7.58−7.46 (m, 3 H), 7.40−7.27 (m,
5 H), 4.64 (d, J = 5.9 Hz, 2 H). 13C NMR [101 MHz, δ (ppm), CDCl3]:
160.8, 147.5, 137.8, 131.7, 130.3, 129.7, 128.9, 128.0, 127.7, 121.6, 43.3.
FTIR [ν̅ (cm−1)]: 3255, 3121, 2945, 1634, 1516, 1059, 768, 751, 683.
HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C15H14N2O2Na
277.0948, found 277.0956. Rf: 0.68 (CH2Cl2/MeOH, 10:0.2). Yield:
39%.
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General Procedure for the Synthesis of Isoxazolidines 4a, 4b,
4d−r. The solution containing alkene 2 in distilled THF (3 equiv, 1.48
M) at 0 °C was added to a PTFE tube containing the corresponding
nitrone 6 (1 equiv) and galvinoxyl (0.03 equiv). The tube was ﬁlled up
with distilled THF, closed and brought to 15 kbar at 50 °C for 16 h.
Then, the reaction mixture was ﬁltered oﬀ, and the solvent was
removed under vacuo. The crude mixture was puriﬁed by column
chromatography using the indicated eluent to aﬀord isoxazolidines 4a,
4b, and 4d−r.
2,3-Diphenyl-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine (4a). Ac-
cording to the general procedure, the reaction of nitrone 6a (26 mg,
0.119 mmol) and alkene 2 in a 1 mL PTFE high-pressure tube aﬀorded
cis-4a (24.9 mg, 0.77 mmol, 65%) as a white solid and a mixture of cis-
and trans-4a and regioisomers 7a (12.6 mg, 0.039 mmol, 33%) as a
yellow oil after column chromatography (heptane/CH2Cl2, 9:1). Total
yield: 98%.
rac-(3R,5R)-2,3-Diphenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (cis-4a). 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.52−
7.47 (m, 2 H), 7.43−7.37 (m, 2 H), 7.35−7.30 (m, 1 H), 7.24−7.18 (m,
2 H), 7.04−6.99, (m, 1 H), 6.99−6.95 (m, 2 H), 6.01 (dd, J = 8.1, 4.4
Hz, 1 H), 4.41 (dd, J = 9.0, 7.1 Hz, 1 H), 3.41 (dddq, J = 13.6, 9.0, 8.1,
0.9 Hz, 1 H), 2.44−2.31 (m, 1 H). 13C NMR [126 MHz, δ (ppm),
CDCl3]: 148.8, 139.8, 130.2 (q, J = 307.7 Hz), 129.3, 128.8, 128.3,
127.2, 123.8, 117.6, 80.5 (q, J = 2.5 Hz), 68.3, 47.2. FTIR [ν ̅ (cm−1)]:
3070, 2963, 1598, 1489, 1258, 1114, 1031, 966, 928, 752, 700. HRMS
(EI) m/z: [M+•] calcd for C16H14F3NOS 325.0748, found 325.0765. Rf:
0.20 (heptane/CH2Cl2, 9:1).
rac-(3R,5S)-2,3-Diphenyl-5-[(tr iﬂuoromethyl)sulfanyl]-
isoxazolidine (trans-4a). 1H NMR [500 MHz, δ (ppm), CDCl3]:
7.50−7.45 (m, 2 H), 7.41−7.36 (m, 2 H), 7.35−7.30 (1 H), 7.25−7.18
(m, 2 H), 7.04−6.98 (m, 2 H), 6.98−6.93 (m, 1 H), 6.07 (dd, J = 6.8,
3.8 Hz, 1 H), 4.90 (t, J = 7.3 Hz, 1 H), 3.02−2.92 (m, 1 H), 2.88 (ddd, J
= 13.3, 7.3, 3.8 Hz, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]:
151.0, 139.9, 129.9 (q, J = 307.8 Hz), 129.2, 128.8, 128.2, 126.7, 122.4,
115.2, 82.3 (q, J = 2.0 Hz), 68.1, 46.3. FTIR [ν̅ (cm−1)]: 3065, 1598,
1489, 1206, 1108, 1049, 842, 796, 665. HRMS (EI) m/z: [M+•] calcd
for C16H14F3NOS 325.0748, found 325.0750. Rf: 0.11 (heptane/
CH2Cl2, 9:1).
3-(4-Fluorophenyl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (4b). According to the general procedure, the reaction of
nitrone 6b (27 mg, 0.125 mmol) and alkene 2 in a 1 mL PTFE high-
pressure tube aﬀorded cis-4b (27.6 mg, 0.080 mmol, 64%) as a white
solid, a mixture of cis- and trans-4b and regioisomers 7b (13.1 mg, 0.038
mmol, 27%) as a yellow oil and trans-4b (3.5 mg, 0.010 mmol, 8%) as a
pale yellow oil, after column chromatography (heptane/CH2Cl2, 9:1).
Total yield: 99%.
rac-(3R,5R)-3-(4-Fluorophenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (cis-4b). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.49−7.43 (m, 2 H), 7.25−7.19 (m, 2 H), 7.11−7.05 (m, 2
H), 7.05−7.01 (m, 1 H), 6.99−6.93 (m, 2 H), 6.01 (dd, J = 8.1, 4.3 Hz,
1 H), 4.40 (dd, J = 9.0, 7.0 Hz, 1 H), 3.39 (dddq, J = 13.7, 9.0, 8.1, 0.9
Hz, 1 H), 2.39−2.28 (m, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]:
162.6 (d, J = 247.0 Hz), 148.6, 135.4 (d, J = 3.1 Hz), 130.1 (q, J = 307.8
Hz), 128.92, 128.91 (d, J = 7.2 Hz), 124.0, 117.7, 116.2 (d, J = 21.6 Hz),
80.5 (q, J = 2.3 Hz), 67.7, 47.1. 19F NMR [471 MHz, δ (ppm), CDCl3]:
−39.9. FTIR [ν ̅ (cm−1)]: 3071, 1597, 1455, 1256, 1226, 1110, 1029,
905, 804, 754. HRMS (EI) m/z: [M+•] calcd for C16H13F4NOS
343.0654, found 343.0650. Rf: 0.26 (heptane/CH2Cl2, 17:3).
rac-(3R,5S)-3-(4-Fluorophenyl)-2-phenyl-5-[(triﬂuoromethyl]-
sulfanyl]isoxazolidine (trans-4b). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.44−7.40 (m, 2 H), 7.25−7.20 (m, 2 H), 7.10−7.04 (m, 2
H), 6.99−6.92 (m, 3 H), 6.05 (dd, J = 6.8, 3.9 Hz, 1 H), 4.88 (t, J = 7.2
Hz, 1 H), 2.98−2.90 (m, 1 H), 2.87 (ddd, J = 13.3, 7.3, 3.9 Hz, 1 H).
13C NMR [126 MHz, δ (ppm), CDCl3]: 162.3 (d, J = 242.3 Hz), 150.7,
135.6, 128.9, 128.4 (d, J = 8.3 Hz), 122.6, 116.2 (d, J = 21.7 Hz), 115.3,
81.2, 67.4, 46.2. The carbon signal of SCF3 was not observed.
19F NMR
[471 MHz, δ (ppm), CDCl3]: −39.4. FTIR [ν ̅ (cm−1)]: 3071, 1686,
1598, 1154, 1052, 937, 693. HRMS (EI) m/z: [M+•] calcd for
C16H13F4NOS 343.0654, found 343.0676. Rf: 0.21 (heptane/CH2Cl2,
17:3).
2-Phenyl-3-(4-tolyl)-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine
(4c). The solution containing alkene 2 (3.0 equiv) in distilled THF
(500 μL) at 0 °C was added to a PTFE tube containing nitrone 6c (1.0
equiv). The tube was ﬁlled up with distilled THF, closed and brought to
15 kbar at 50 °C for 16 h. Then, the reaction mixture was ﬁltered oﬀ
and the solvent was removed under vacuo. The crude mixture was
puriﬁed by column chromatography (heptane/CH2Cl2, 4:1) to aﬀord
isoxazolidine cis-4c (17.1 mg, 0.050 mmol, 50%) as white solid and
trans-4c (12.1 mg, 0.36 mmol, 35%) as a brown oil, contaminated with
regioisomers 7c and azoxybenzene 8. Total yield: 85%.
rac-(3R,5R)-2-Phenyl-3-(4-tolyl)-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (cis-4c). 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.40−
7.34 (m, 2 H), 7.23−7.16 (m, 4 H), 7.03−6.95 (m, 3 H), 6.00 (dd, J =
8.1, 4.3 Hz, 1 H), 4.36 (dd, J = 9.0, 7.2 Hz, 1 H), 3.38 (dddq, J = 13.7,
9.0, 8.1, 0.9 Hz, 1 H), 2.39−2.32 (m, 1 H), 2.36 (s, 3 H). 13C NMR
[126 MHz, δ (ppm), CDCl3]: 148.9, 138.1, 136.6, 130.2 (q, J = 307.7
Hz), 130.0, 128.8, 127.1, 123.7, 117.6, 80.5 (q, J = 2.2 Hz), 68.1, 47.3,
21.3. 19F NMR [471 MHz, δ (ppm), CDCl3]: −39.9. FTIR [ν ̅ (cm−1)]:
3056, 2962, 1597, 1489, 1257, 1107, 752, 691. HRMS (EI) m/z: [M+•]
calcd for C17H16F3NOS 339.0905, found 339.0890. Rf: 0.21 (heptane/
CH2Cl2, 4:1).
rac-(3R,5S)-2-Phenyl-3-(4-tolyl)-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (trans-4c). 1H NMR [500 MHz, δ (ppm), CDCl3]:
7.36−7.33 (m, 2 H), 7.25−7.16 (m, 4 H), 7.02−6.98 (m, 2 H), 6.97−
6.92 (m, 1 H), 6.06 (dd, J = 6.8, 3.8 Hz, 1 H), 4.85 (t, J = 7.2 Hz, 1 H),
2.95 (dddq, J = 13.2, 7.6, 6.8, 0.9 Hz, 1 H), 2.85 (ddd, J = 13.2, 7.2, 3.8
Hz, 1 H), 2.36 (s, 3 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 151.0,
137.9, 136.9, 130.1 (q, J = 307.7 Hz), 129.8, 128.8, 126.6, 122.2, 115.2,
82.3 (q, J = 2.2 Hz), 67.9, 46.4, 21.3. 19F NMR [471 MHz, δ (ppm),
CDCl3]: −39.3. FTIR [ν̅ (cm−1)]: 3063, 2925, 1599, 1487, 1152, 1053,
756, 686. HRMS (EI) m/z: [M+•] calcd for C17H16F3NOS 339.0905,
found 339.0924. Rf: 0.13 (heptane/CH 2Cl2, 4:1).
2-Phenyl-3-[4-(triﬂuoromethyl)phenyl]-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (4d). According to the general procedure, the
reaction of nitrone 6d (50 mg, 0.190 mmol) and alkene 2 in a 1.5 mL
PTFE high-pressure tube, containing approximately 300 μL of glass
beads, aﬀorded a mixture of isoxazolidines cis- and trans-4d and
regioisomers 7d (53.1 mg, 0.137 mmol, 73%) as a pale yellow solid oil,
after column chromatography (heptane/CH2Cl2, 17:3). FTIR [ν ̅
(cm−1)]: 1597, 1490, 1325, 1104, 1051, 850, 754, 692. HRMS (EI) m/
z: [M+•] calcd for C17H13F6NOS 393.0622, found 393.0624. Rf: 0.20
(heptane/CH2Cl2, 17:3). Total yield: 73%.
rac-(3R,5R)-2-Phenyl-3- [4- ( tr iﬂuoromethyl)phenyl] -5-
[(triﬂuoromethyl)sulfanyl]isoxazolidine (cis-4d). 1H NMR [500 MHz,
δ (ppm), CDCl3]: 7.72−7.55 (m, 4 H), 7.25−7.18 (m, 2 H), 7.05−7.00
(m, 1 H), 6.97−6.93 (m, 2 H), 6.00 (dd, J = 8.0, 4.3 Hz, 1 H), 4.50 (dd,
J = 9.1, 6.7, 1 H), 3.43 (dddq, J = 13.7, 9.1, 8.0, 0.9, 1 H), 2.33 (ddd, J =
13.7, 6.7, 4.3 Hz, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.4,
144.1, 130.6 (q, J = 32.6 Hz), 130.0 (q, J = 307.8 Hz), 129.0, 127.4,
126.3 (q, J = 3.8 Hz), 124.09 (q, J = 272.1 Hz), 124.05, 117.4, 80.4 (q, J
= 2.2 Hz), 67.5, 46.9.
rac- (3R,5S)-2-Phenyl-3- [4- ( t r iﬂuoromethyl )phenyl ] -5-
[(triﬂuoromethyl)sulfanyl]isoxazolidine (trans-4d). 1H NMR [500
MHz, δ (ppm), CDCl3]: 7.70−7.56 (m, 4 H), 7.27−7.18 (m, 2 H),
7.00−6.96 (m, 3 H), 6.04 (dd, J = 6.3, 4.6 Hz, 1 H), 4.97 (t, J = 7.1 Hz,
1 H), 3.01−2.83 (m, 2 H). 13C NMR [126 MHz, δ (ppm), CDCl3]:
150.5, 144.1, 130.5 (q, J = 32.5 Hz), 130.0 (q, J = 307.8 Hz), 129.0,
127.0, 126.2 (q, J = 3.9 Hz), 122.7, 115.1, 82.2 (q, J = 2.1 Hz), 67.5,
45.9.
3-[4-(Pentaﬂuoro-λ6-sulfanyl)phenyl]-2-phenyl-5-[(triﬂuoro-
methyl)sulfanyl]isoxazolidine (4e). According to the general proce-
dure, the reaction of nitrone 6e (37.8 mg, 0.143 mmol) and alkene 2 in
a 1 mL PTFE high-pressure tube aﬀorded a mixture of isoxazolidines
cis- and trans-4e and regioisomers 7e (41 mg, 0.091 mmol, 72%) as a
white solid, after column chromatography (heptane/CH2Cl2, 17:3).
FTIR [ν̅ (cm−1)]: 2963, 1670, 1585, 1261, 1120, 1104, 817, 753, 584.
HRMS (EI) m/z: [M+•] calcd for C16H13F8NOS2 451.0311, found
451.0318. Rf: 0.21 (heptane/CH2Cl2, 17:3). Total yield: 72%.
rac-(3R,5R)-3-[4-(Pentaﬂuoro-λ6-sulfanyl)phenyl]-2-phenyl-5-
[(triﬂuoromethyl)sulfanyl]isoxazolidine (cis-4e). 1H NMR [500 MHz,
δ (ppm), CDCl3]: 7.85−7.72 (m, 2 H), 7.64−7.55 (m, 2 H), 7.30−7.21
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(m, 2 H), 7.09−7.02 (m, 1 H), 7.02−6.92 (m, 2 H), 6.00 (dd, J = 8.0,
4.3 Hz, 1 H), 4.52 (dd, J = 9.2, 6.6, 1 H), 3.43 (dt, J = 13.7, 8.6, 1 H),
2.32 (ddd, J = 13.7, 6.6, 4.3 Hz, 1 H). 13C NMR [126 MHz, δ (ppm),
CDCl3]: 153.7−153.4 (m), 148.3, 144.0, 130.0 (q, J = 307.9 Hz), 129.1,
127.3, 127.0, 124.2, 117.3, 80.4 (q, J = 2.3 Hz), 67.1, 46.7.
rac-(3R,5S)-3-[4-(Pentaﬂuoro-λ6-sulfanyl)phenyl]-2-phenyl-5-
[(triﬂuoromethyl)sulfanyl]isoxazolidine (trans-4e). 1H NMR [500
MHz, δ (ppm), CDCl3]: 7.80−7.74 (m, 2 H), 7.60−7.56 (m, 2 H),
7.28−7.21 (m, 2 H), 7.01−6.97 (m, 3 H), 6.03 (dd, J = 5.9, 5.0, 1 H),
4.97 (t, J = 7.1 Hz, 1 H), 3.01−2.80 (m, 2 H). 13C NMR [126 MHz, δ
(ppm), CDCl3]: 153.7−153.4 (m), 150.4, 143.9, 130.0 (q, J = 307.9
Hz), 129.0, 127.1, 127.0, 122.8, 115.1, 82.2 (q, J = 2.2 Hz), 67.1, 45.8.
3-(4-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (4f). According to the general procedure, the reaction of
nitrone 6f (54 mg, 0.238 mmol) and alkene 2 in a 1.5 mL PTFE high-
pressure tube aﬀorded isoxazolidine cis-4f (44.3 mg, 0.125 mmol, 53%),
a mixture of isoxazolidines cis- and trans-4f (27.3 mg, 0.077 mmol, 32%)
and isoxazolidine trans-4f mixed with cis-4f and regioisomers 7f (12.4
mg, 0.035 mmol, 15%) as yellow oils, after column chromatography
(heptane/CH2Cl2, 7:3). Total yield: 99%.
rac-(3R,5R)-3-(4-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (cis-4f). 1H NMR [500 MHz, δ (ppm), CDCl3]:
7.43−7.35 (m, 2 H), 7.23−7.18 (m, 2 H), 7.04−6.99 (m, 1 H), 6.99−
6.95 (m, 2 H), 6.94−6.90 (m, 2 H), 6.01 (dd, J = 8.1, 4.3 Hz, 1 H), 4.34
(dd, J = 8.9, 7.3 Hz, 1 H), 3.82 (s, 3 H), 3.37 (dddq, J = 13.8, 8.9, 8.2,
0.9 Hz, 1 H), 2.46−2.25 (m, 1 H). 13C NMR [126 MHz, δ (ppm),
CDCl3]: 159.6, 148.8, 131.4, 130.2 (q, J = 307.8 Hz), 128.8, 128.4,
123.8, 117.8, 114.6, 80.5 (q, J = 2.2 Hz), 68.0, 55.4, 47.2. 19F NMR [471
MHz, δ (ppm), CDCl3]: −39.9. FTIR [ν ̅ (cm−1)]: 3003, 1614, 1515,
1298, 1103, 1031, 816, 773. HRMS (EI) m/z: [M+•] calcd for
C17H16F3NO2S 355.0854, found 355.0861. Rf: 0.15 (heptane/CH2Cl2,
4:1).
rac-(3R,5S)-3-(4-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (trans-4f). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.38−7.35 (m, 2 H), 7.22−7.18 (m, 2 H), 7.01−6.98 (m, 2
H), 6.97−6.93 (m, 1 H), 6.92−6.89 (m, 2 H), 6.06 (dd, J = 6.8, 3.7 Hz,
1 H), 4.87−4.77 (m, 1 H), 3.81 (s, 3 H), 3.00−2.90 (m, 1 H), 2.84
(ddd, J = 13.2, 7.2, 3.7 Hz, 1 H). 13C NMR [126 MHz, δ (ppm),
CDCl3]: 159.5, 151.0, 131.8, 130.0 (q, J = 307.8 Hz), 128.8, 127.9,
122.4, 115.4, 114.5, 82.3 (q, J = 2.3 Hz), 67.7, 55.5, 46.3. FTIR [ν̅
(cm−1)]: 3002, 1512, 1489, 1248, 1109, 1030, 794, 693. HRMS (EI)m/
z: [M+•] calcd for C17H16F3NO2S 355.0854, found 355.0855. Rf: 0.10
(heptane/CH2Cl2, 4:1).
3-(3-Fluorophenyl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (4g). According to the general procedure, the reaction of
nitrone 6g (52 mg, 0.242 mmol) and alkene 2 in a 1.5 mL PTFE high-
pressure tube aﬀorded isoxazolidine cis-4g (46.6 mg, 0.136 mmol, 56%)
as a white solid, a mixture of cis- and trans-4g (27.8 mg, 0.081, 34%) as a
yellow oil, and isoxazolidine trans-4g mixed with cis-4g and
regioisomers 7g (8.5 mg, 0.025 mmol, 10%) as a yellow solid, after
column chromatography (heptane/CH2Cl2, 9:1). Total yield: 99%.
rac-(3R,5R)-3-(3-Fluorophenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (cis-4g). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.34 (td, J = 8.1, 5.9 Hz, 1 H), 7.28−7.18 (m, 4 H), 7.06−
6.98 (m, 2 H), 6.98−6.93 (m, 2 H), 5.98 (dd, J = 8.1, 4.3 Hz, 1 H), 4.41
(dd, J = 9.1, 6.8 Hz, 1 H), 3.39 (dddq, J = 13.7, 9.1, 8.1, 0.9 Hz, 1 H),
2.33 (ddd, J = 13.7, 6.8, 4.3 Hz, 1 H). 13C NMR [126 MHz, δ (ppm),
CDCl3]: 163.4 (d, J = 247.0 Hz), 148.6, 142.5 (d, J = 7.2 Hz), 130.9 (d,
J = 8.3 Hz), 130.1 (q, J = 307.9 Hz), 128.9, 123.9, 122.7 (d, J = 2.9 Hz),
117.4, 115.3 (d, J = 21.3 Hz), 114.1 (d, J = 22.6 Hz), 80.4 (q, J = 2.4
Hz), 67.5 (d, J = 1.9 Hz), 46.9. 19F NMR [471 MHz, δ (ppm), CDCl3]:
−39.9. FTIR [ν ̅ (cm−1)]: 3062, 1594, 1489, 1448, 1258, 1111, 1044,
915, 833, 752, 690. HRMS (EI) m/z: [M+•] calcd for C16H13F4NOS
343.0654, found 343.0675. Rf: 0.22 (heptane/CH2Cl2, 17:3).
rac-(3R,5S)-3-(3-Fluorophenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (trans-4g). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.35 (td, J = 8.1, 5.9 Hz, 1 H), 7.25−7.20 (m, 4 H), 7.04−6.94
(m, 4 H), 6.05 (dd, J = 6.8, 4.0 Hz, 1 H), 4.90 (t, J = 7.4 Hz, 1 H), 2.99−
2.91 (m, 1 H), 2.33 (ddd, J = 13.2, 7.4, 4.0 Hz, 1 H). 13C NMR [126
MHz, δ (ppm), CDCl3]: 163.4 (d, J = 247.1 Hz), 150.6, 142.6 (d, J =
7.2 Hz), 130.7 (d, J = 8.3 Hz), 128.9, 122.6, 122.2 (d, J = 2.8 Hz), 115.2
(d, J = 21.6 Hz), 115.1, 113.7 (d, J = 22.7 Hz), 80.2 (q, J = 2.5 Hz), 67.4
(d, J = 2.1 Hz), 46.0. 19F NMR [471 MHz, δ (ppm), CDCl3]: −39.4.
FTIR [ν̅ (cm−1)]: 3070, 1593, 1488, 1451, 1256, 1109, 947, 787, 691.
HRMS (EI) m/z: [M+•] calcd for C16H13F4NOS 343.0654, found
343.0667. Rf: 0.15 (heptane/CH2Cl2, 17:3).
2-Phenyl-3-(3-tolyl)-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine
(4h). According to the general procedure, the reaction of nitrone 6h
(49 mg, 0.234 mmol) and alkene 2 in a 1.5 mL PTFE high-pressure
tube aﬀorded isoxazolidine cis-4h (46 mg, 0.136 mmol, 57%) as an oﬀ
white solid and isoxazolidine trans-4h and regioisomers 7h (26 mg,
0.077 mmol, 31%) as a yellow solid, after column chromatography
(heptane/CH2Cl2, 17:3 → 7:3). Total yield: 88%.
rac-(3R,5R)-2-Phenyl-3-(3-tolyl)-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (cis-4h). 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.31−
7.28 (m, 1 H), 7.27−7.24 (m, 2 H), 7.22−7.17 (m, 2 H), 7.14−7.10 (m,
1 H), 7.02−6.94 (m, 3 H), 5.98 (dd, J = 8.1, 4.4 Hz, 1 H), 4.35 (dd, J =
9.0, 7.2 Hz, 1 H), 3.37 (dddq, J = 13.6, 9.0, 8.1, 0.9 Hz, 1 H), 2.38−2.32
(m, 1 H), 2.36 (s, 3 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.9,
139.7, 139.1, 130.2 (q, J = 307.7 Hz), 129.1, 129.1, 128.8, 127.6, 124.2,
123.6, 117.5, 80.5 (q, J = 2.2 Hz), 68.3, 47.2, 21.6. FTIR [ν̅ (cm−1)]:
3028, 1599, 1489, 1040, 1001, 839, 737, 724, 692. HRMS (EI) m/z:
[M+•] calcd for C17H16F3NOS 339.0905, found 339.0925. Rf: 0.41
(heptane/CH2Cl2, 4:1).
rac-(3R,5S)-2-Phenyl-3-(3-tolyl)-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (trans-4h). 1H NMR [500 MHz, δ (ppm), CDCl3]:
7.31−7.18 (m, 5 H), 7.14−7.10 (m, 1 H), 7.03−6.98 (m, 2 H), 6.98−
6.91 (m, 1 H), 6.06 (dd, J = 6.8, 3.7 Hz, 1 H), 4.85 (t, J = 7.3 Hz, 1 H),
2.95 (dddq, J = 13.2, 7.6, 6.8, 0.9 Hz, 1 H), 2.86 (ddd, J = 13.2, 7.3, 3.7
Hz, 1 H), 2.36 (s, 3 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 151.2,
139.9, 139.0, 130.0 (q, J = 307.8 Hz), 129.0, 128.9, 128.8, 127.1, 123.7,
122.3, 115.1, 82.4 (q, J = 2.1 Hz), 68.1, 46.4, 21.6. 19F NMR [471 MHz,
δ (ppm), CDCl3]: −39.3. FTIR [ν ̅ (cm−1)]: 3029, 1598, 1489, 1150,
1111, 1045, 785, 692. HRMS (EI) m/z: [M+•] calcd for C17H16F3NOS
339.0905, found 339.0931. Rf: 0.34 (heptane/CH2Cl2, 4:1).
Methyl 3-{2-Phenyl-5-[(triﬂuoromethyl)sulfanyl]isoxazolidin-3-
yl}benzoate (4i). According to the general procedure, the reaction of
nitrone 6i (26 mg, 0.102 mmol) and alkene 2 in a 1 mL PTFE high-
pressure tube, containing approximately 150 μL of glass beads, aﬀorded
isoxazolidine cis-4i (17.3 mg, 0.045 mmol, 44%) as an oﬀ-white solid
and a mixture of isoxazolidines cis- and trans-4i and regioisomers 7i
(18.2 mg, 0.047 mmol, 47%) as a brown-yellow solid, after column
chromatography (heptane/CH2Cl2, 3:2). Total yield: 91%.
Methyl 3-{rac-(3R,5R)-2-Phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidin-3-yl}benzoate (cis-4i). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 8.11 (t, J = 1.8 Hz, 1 H), 8.01 (dt, J = 7.7, 1.4 Hz, 1 H), 7.76
(dddd, J = 7.7, 1.8, 1.2, 0.5 Hz, 1 H), 7.48 (t, J = 7.7 Hz, 1 H), 7.24−
7.19 (m, 2 H), 7.07−7.00 (m, 1 H), 6.98−6.94 (m, 2 H), 6.01 (dd, J =
8.0, 4.5 Hz, 1 H), 4.50 (dd, J = 8.9, 7.0 Hz, 1 H), 3.93 (s, 3 H), 3.43
(dddq, J = 13.6, 8.9, 8.0, 0.9 Hz, 1 H), 2.42−2.30 (m, 1 H). 13C NMR
[126 MHz, δ (ppm), CDCl3]: 166.8, 148. 6, 140.4, 131.6, 131.1, 130.0
(q, J = 307.7 Hz), 129.6, 129.0, 128.3, 124.0, 117.6, 80.4 (q, J = 2.5 Hz),
67.9, 52.4, 46.9. 19F NMR [471 MHz, δ (ppm), CDCl3]: −39.9. FTIR
[ν̅ (cm−1)]: 3015, 1729, 1598, 1489, 1301, 1247, 1114, 1025, 786, 692,
674. HRMS (EI) m/z: [M+•] calcd for C18H16F3NO3S 383.0803, found
383.0824. Rf: 0.27 (heptane/CH2Cl2, 3:2).
Methyl-3-{rac-(3R,5S)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidin-3-yl}benzoate (trans-4i). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 8.12 (t, J = 1.8 Hz, 1 H), 8.02−7.98 (m, 1 H), 7.69 (dt, J = 7.8,
1.6 Hz, 1 H), 7.47 (t, J = 7.7, 1 H), 7.26−7.18 (m, 2 H), 7.00−6.98 (m,
2 H), 6.97−6.94 (m, 1 H), 6.06 (dd, J = 6.7, 4.0 Hz, 1 H), 4.96 (t, J =
7.3 Hz, 1 H), 3.93 (s, 3 H), 3.01−2.94 (m, 1 H), 2.91 (ddd, J = 13.3,
7.4, 4.0 Hz, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 166.8, 150.7,
140.5, 131.19, 131.14, 130.0 (q, J = 307.9 Hz), 129.57, 129.55, 128.9,
127.8, 122.6, 115.2, 82.3 (q, J = 2.2 Hz), 67.6, 52.4, 46.1. 19F NMR [471
MHz, δ (ppm), CDCl3]: −39.4. FTIR [ν ̅ (cm−1)]: 3064, 1720, 1598,
1489, 1285, 1107, 1020, 799, 751, 692. HRMS (EI) m/z: [M+•] calcd
for C18H16F3NO3S 383.0803, found 383.0810. Rf: 0.22 (heptane/
CH2Cl 2, 3:2).
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3-(3-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (4j). According to the general procedure, the reaction of
nitrone 6j (50 mg, 0.190 mmol) and alkene 2 in a 1.5 mL PTFE high-
pressure tube, containing approximately 300 μL of glass beads, aﬀorded
isoxazolidine cis-4j (33.8 mg, 0.095 mmol, 53%) as a white solid, a
mixture of isoxazolidines cis- and trans-4j (3 mg, 0.0084 mmol, 5%) as a
yellow oil and isoxazolidines trans-4j and 7j (18.2 mg, 0.051 mmol,
22%) as a yellow oil, after column chromatography (heptane/CH2Cl2,
7:3). Total yield: 80%.
rac-(3R,5R)-3-(3-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (cis-4j). 1H NMR [400 MHz, δ (ppm), CDCl3]:
7.29 (t, J = 7.9 Hz, 1 H), 7.24−7.17 (m, 2 H), 7.09−6.95 (m, 5 H), 6.85
(ddd, J = 8.3, 2.7, 1.1 Hz, 1 H), 5.99 (dd, J = 8.1, 4.3 Hz, 1 H), 4.37 (dd,
J = 9.1, 7.0 Hz, 1 H), 3.81 (s, 3 H), 3.43−3.32 (m, 1 H), 2.36 (ddd, J =
13.7, 7.0, 4.3 Hz, 1 H). 13C NMR [101 MHz, δ (ppm), CDCl3]: 160.4,
148.9, 141.6, 130.3, 130.2 (q, J = 307.7 Hz), 128.8, 123.6, 119.3, 117.3,
113.8, 112.4, 80.5 (q, J = 2.5 Hz), 68.0, 55.4, 47.2 (q, J = 1.2 Hz). 19F
NMR [377 MHz, δ (ppm), CDCl3]: −39.9. FTIR [ν̅ (cm−1)]: 3006,
2838, 1599, 1490, 1117, 757, 694. HRMS (EI) m/z: [M+•] calcd for
C17H16F3NO 2S 355.0854, found 355.0868. Rf: 0.16 (heptane/CH2Cl2,
7:3).
rac-(3R,5S)-3-(3-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (trans-4j). 1H NMR [400 MHz, δ (ppm),
CDCl3]: 7.29 (t, J = 8.1 Hz, 1 H), 7.25−7.19 (m, 2 H), 7.07−6.92 (m, 5
H), 6.89−6.81 (m, 1 H), 6.06 (dd, J = 6.8, 3.8, 1 H), 4.86 (t, J = 7.4 Hz,
1 H), 3.81 (s, 3 H), 2.96 (dddq, J = 13.3, 7.6, 6.8, 0.9 Hz, 1 H), 2.87
(ddd, J = 13.3, 7.3, 3.8 Hz, 1 H). 13C NMR [101 MHz, δ (ppm),
CDCl3]: 160.3, 151.0, 141.6, 130.2, 130.0 (q, J = 307.8 Hz), 128.8,
122.3, 118.8, 115.1, 113.7, 112.0, 82.3 (q, J = 2.3 Hz), 68.0, 55.5, 46.3.
19F NMR [377 MHz, δ (ppm), CDCl3]: −39.3. FTIR [ν̅ (cm−1)]:
3064, 1720, 1598, 1489, 1347, 1107, 1020, 799, 750, 692. HRMS (ESI-
TOF) m/z: [M + H]+ calcd for C17H17F3NO2S 356.0932, found
356.0939. Rf: 0.13 (heptane/CH2Cl2, 7:3).
2-Phenyl-3-[3-(triﬂuoromethyl)phenyl]-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (4k). According to the general procedure, the
reaction of nitrone 6k (49 mg, 0.234 mmol) and alkene 2 in a 1.5 mL
PTFE high-pressure tube aﬀorded a mixture of isoxazolidines cis- and
trans-4k and 7k (87.4 mg, 0.222 mmol, 95%) as a white-yellow solid,
after column chromatography (heptane/CH2Cl2, 17:3→ 7:3). FTIR [ν̅
(cm−1)]: 2927, 1598, 1490, 1263, 1144, 1045. HRMS (EI) m/z: [M+•]
calcd for C17H13F6NOS 393.0622, found 393.0639. Rf: 0.38 (heptane/
CH2Cl2, 4:1). Total yield: 95%.
rac-(3R,5R)-2-Phenyl -3-[3-( t r iﬂuoromethyl )phenyl ]-5-
[(triﬂuoromethyl)sulfanyl]isoxazolidine (cis-4k). 1H NMR [500 MHz,
δ (ppm), CDCl3]: 7.73−7.69 (m, 2 H), 7.60−7.56 (m, 1 H), 7.54−7.48
(m, 1 H), 7.26−7.20 (m, 2 H), 7.05−7.00 (m, 1 H), 6.98−6.93 (m, 2
H), 5.99 (dd, J = 8.0, 4.5 Hz, 1 H), 4.51 (dd, J = 9.0, 6.7 Hz, 1 H), 3.41
(dddq, J = 13.6, 9.0, 8.0, 0.8 Hz, 1 H), 2.37−2.28 (m, 1 H). 13C NMR
[126 MHz, δ (ppm), CDCl3]: 148.6, 141.1, 131.6 (q, J = 32.4 Hz),
130.4 (q, J = 1.2 Hz), 129.9 (q, J = 308.0 Hz), 129.9, 129.0, 125.2 (q, J =
3.8 Hz), 124.0 (q, J = 272.4 Hz), 124.1, 123.9 (q, J = 3.8 Hz), 117.4,
80.4 (q, J = 2.5 Hz), 67.8, 46.8.
rac-(3R,5S)-2-Phenyl-3-[3-(triﬂuoromethyl)phenyl]-5-[(triﬂuoro-
methyl)sulfanyl]isoxazolidine (trans-4k). 1H NMR [500 MHz, δ
(ppm), CDCl3]: 7.73−7.70 (m, 1 H), 7.68−7.64 (m, 1 H), 7.60−7.56
(m, 1 H), 7.53−7.48 (m, 1 H), 7.26−7.20 (m, 2 H), 6.92−6.88 (m, 3
H), 6.06−6.02 (m, 1 H), 4.96 (t, J = 7.2 Hz, 1 H), 2.98−2.86 (m, 2 H).
13C NMR [126 MHz, δ (ppm), CDCl3]: 150.6, 141.1, 131.6 (q, J = 32.4
Hz), 130.4 (q, J = 1.2 Hz), 129.7, 128.9, 125.1 (q, J = 4.0 Hz), 123.5 (q,
J = 3.8 Hz), 122.7, 115.2, 82.3 (q, J = 2.4 Hz), 67.5, 46.0.
2-Phenyl-3-(2-tolyl)-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine
(4l). According to the general procedure, the reaction of nitrone 6l (49
mg, 0.234 mmol) and alkene 2 in a 1.5 mL PTFE high-pressure tube
aﬀorded isoxazolidine cis-4l (1.9 mg, 0.0056 mmol; used for
characterization) as a colorless oil and a mixture of isoxazolidines cis-
and trans-4l (79.5 mg, 0.234 mmol, 99%) as a yellow solid, after column
chromatography (heptane/CH2Cl2, 4:1). FTIR [ν ̅ (cm−1)]: 3025,
1596, 1489, 1258, 1109, 1041, 972, 754, 695. HRMS (EI) m/z: [M+•]
calcd for C17H16F3NOS 339.0905, found 339.0923. Rf: 0.23 (heptane/
CH2Cl2, 4:1). Total yield: 99%.
rac-(3R,5R)-2-Phenyl-3-(2-tolyl)-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (cis-4l). 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.72
(dd, J = 7.2, 1.7 Hz, 1 H), 7.26−7.17 (m, 5 H), 7.00 (tt, J = 7.4, 1.2 Hz,
1 H), 6.96−6.88 (m, 2 H), 6.01 (dd, J = 8.1, 4.2 Hz, 1 H), 4.61 (dd, J =
9.1, 7.1 Hz, 1 H), 3.44 (dddq, J = 13.5, 9.1, 8.1, 0.9 Hz, 1 H), 2.35 (s, 3
H), 2.25 (ddd, J = 13.5, 7.1, 4.2 Hz, 1 H). 13C NMR [126 MHz, δ
(ppm), CDCl3]: 148.9, 138.0, 134.6, 130.8, 130.1 (q, J = 307.4 Hz),
128.9, 127.8, 127.3, 126.6, 123.5, 117.2, 80.5 (q, J = 2.2 Hz), 64.5, 45.6,
19.7. 19F NMR [471 MHz, δ (ppm), CDCl3]: −40.0.
rac-(3R,5S)-2-Phenyl-3-(2-tolyl)-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (trans-4l). 1H NMR [500 MHz, δ (ppm), CDCl3]:
7.65−7.62 (m, 1 H), 7.27−7.15 (m, 5 H), 6.97−6.93 (m, 3 H), 6.06
(dd, J = 6.7, 3.9 Hz, 1 H), 5.04 (t, J = 7.5 Hz, 1 H), 2.89 (ddd, J = 13.1,
7.5, 3.9 Hz, 1 H), 2.80 (dddq, J = 13.1, 7.5, 6.7, 0.9 Hz, 1 H), 2.39 (s, 3
H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 151.1, 137.8, 134.3, 130.8,
128.7, 127.8, 127.0, 126.2, 122.1, 114.7, 82.2 (q, J = 2.3 Hz), 65.3, 44.6,
19.4.
3-(2-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (4m). According to the general procedure, the reaction of
nitrone 6m (53 mg, 0.234 mmol) and alkene 2 in a 1.5 mL PTFE high-
pressure tube aﬀorded isoxazolidine cis-4m (35.6 mg, 0.100 mmol,
43%) as an oﬀ white solid and a mixture of isoxazolidines cis- and trans-
4m (29.6 mg, 0.083 mmol, 28%) as a yellow solid, after column
chromatography (heptane/CH2Cl2, 7:3). Total yield: 71%.
rac-(3R,5R)-3-(2-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (cis-4m). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.65 (dd, J = 7.6, 1.7 Hz, 1 H), 7.28 (ddd, J = 8.2, 7.5, 1.8 Hz, 1
H), 7.25−7.19 (m, 2 H), 7.01−6.94 (m, 4 H), 6.91 (dd, J = 8.3, 1.0 Hz,
1 H), 5.94 (dd, J = 8.0, 4.5 Hz, 1 H), 4.87 (dd, J = 9.1, 6.1 Hz, 1 H), 3.86
(s, 3 H), 3.40 (dddq, J = 13.6, 9.1, 8.0, 0.9 Hz, 1 H), 2.30−2.20 (m, 1
H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 156.3, 149.4, 130.3 (q, J =
307.7 Hz), 128.9, 128.4, 127.5, 123.1, 121.3, 116.7, 110.5, 80.6 (q, J =
2.4 Hz), 62.1, 55.5, 45.0. FTIR [ν ̅ (cm−1)]: 3075, 1599, 1490, 1243,
1106, 1027, 897, 751, 664. HRMS (EI) m/z: [M+•] calcd for
C17H16F3NO2S 355.0854, found 355.0875. Rf: 0.19 (heptane/CH2Cl2,
7:3).
rac-(3R,5S)-3-(2-Methoxyphenyl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (trans-4m). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.59 (dd, J = 7.6, 1.5 Hz, 1 H), 7.31−7.26 (m, 2 H), 7.06−7.02
(m, 2 H), 7.00−6.88 (m, 4 H), 5.99−5.96 (m, 1 H), 5.26 (dd, J = 7.5,
5.8 Hz, 1 H), 3.88 (s, 3 H), 2.90 (ddd, J = 12.7, 7.5, 5.0 Hz, 1 H), 2.84−
2.76 (m, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 156.3, 151.2,
128.9, 128.8, 128.1, 127.2, 122.0, 121.1, 114.9, 110.4, 82.4 (q, J = 2.2
Hz), 62.9, 55.5, 43.7. The carbon signal of SCF3 was not observed.
FTIR [ν̅ (cm−1)]: 2839, 1599, 1490, 1256, 1106, 1026, 751, 692.
HRMS (EI) m/z: [M+•] calcd for C17H16F3NO2S 355.0854, found
355.0862. Rf: 0.15 (heptane/CH2Cl2, 7:3).
2-Phenyl-3-(thiophen-3-yl)-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (4n). According to the general procedure, the reaction of
nitrone 6n (48 mg, 0.234 mmol) and alkene 2 in a 1.5 mL PTFE high-
pressure tube aﬀorded a mixture of isoxazolidines cis- and trans-4n
(68.4 mg, 0.206 mmol, 88%) as a yellow solid, after column
chromatography (heptane/CH2Cl2, 3:2). FTIR [ν ̅ (cm−1)]: 3095,
1598, 1489, 1257, 1163, 1110, 1031, 837, 792, 754, 692. HRMS (EI)
m/z: [M+•] calcd for C14H12F3NOS2 331.0312, found 331.0330. Rf:
0.19 (heptane/CH2Cl2, 17:3). Total yield: 88%.
rac-(3R,5R)-2-Phenyl-3-(thiophen-3-yl)-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (cis-4n). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.36 (dd, J = 5.0, 3.0 Hz, 1 H), 7.30−7.27 (m, 1 H), 7.25−
7.20 (m, 2 H), 7.19 (dd, J = 5.0, 1.3 Hz, 1 H), 7.02 (tt, J = 7.4, 1.2 Hz, 1
H), 7.00−6.96 (m, 2 H), 6.00 (dd, J = 8.2, 4.2 Hz, 1 H), 4.51 (dd, J =
8.8, 6.7 Hz, 1 H), 3.36−3.28 (m, 1 H), 2.38 (ddd, J = 13.6, 6.7, 4.2 Hz, 1
H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 148.9, 140.4, 130.2 (q, J =
307.7 Hz), 128.8, 127.3, 126.1, 123.9, 122.7, 117.5, 80.5 (q, J = 2.5 Hz),
64.6, 45.9.
rac-(3R,5S)-2-Phenyl-3-(thiophen-3-yl)-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (trans-4n). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 7.32 (dd, J = 5.0, 3.0 Hz, 1 H), 7.30−7.27 (m, 1 H), 7.26−7.20
(m, 2 H), 7.09 (dd, J = 5.0, 1.4 Hz, 1 H), 7.06−6.95 (m, 3 H), 6.03 (dd,
J = 7.2, 4.9 Hz, 1 H), 5.01 (t, J = 6.5 Hz, 1 H), 2.96 (dt, J = 13.0, 6.4 Hz,
1 H), 2.78 (ddd, J = 12.7, 7.3, 4.7 Hz, 1 H). 13C NMR [126 MHz, δ
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(ppm), CDCl3]: 150.2, 140.6, 130.2 (q, J = 307.7 Hz), 128.8, 127.0,
125.8, 122.7, 122.4, 115.7, 81.9 (q, J = 2.2 Hz), 64.2, 44.6.
3-(1H-Indol-2-yl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (4o). According to the general procedure, the reaction of
nitrone 6o (56 mg, 0.237 mmol) and alkene 2 in a 1.5 mL PTFE high-
pressure tube aﬀorded isoxazolidines cis- and trans-4o (20.3 mg, 0.056
mmol, 24%; contaminated with 8) as a brown-yellow oil and a mixture
of isoxazolidine trans-4o and regioisomers 7o (35.6 mg, 0.098 mmol,
41%) as a brown oil, after column chromatography (heptane/CH2Cl2,
11:9). FTIR [ν ̅ (cm−1)] of isoxazolidines cis- and trans-4o: 3413, 3060,
2962, 1599, 1436, 1258, 1110, 1022, 788, 756, 684, 660. FTIR [ν̅
(cm−1)] of isoxazolidine trans-4o and regioisomers 7o: 3406, 3059,
2963, 1597, 1455, 1231, 1107, 1014, 793, 693. Total yield: 65%.
rac-(3R,5R)-3-(1H-Indol-2-yl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (cis-4o). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 8.67 (bs, 1 H), 7.61−7.58 (m, 1 H), 7.40−7.37 (m, 1 H),
7.25−7.18 (m, 3 H), 7.15−7.12 (m, 1 H), 7.05−7.02 (m, 3 H), 6.50 (d,
J = 2.0 Hz, 1 H), 6.07 (dd, J = 8.3, 3.5 Hz, 1 H), 4.77 (dd, J = 9.4, 5.6
Hz, 1 H), 3.44−3.32 (m, 1 H), 2.50 (ddd, J = 13.8, 5.6, 3.5 Hz, 1 H).
13C NMR [126 MHz, δ (ppm), CDCl3]: 148.6, 136.2, 135.6, 130.0 (q, J
= 306.8 Hz), 129.1, 128.6, 123.9, 122.6, 120.6, 120.4, 116.7, 111.5,
100.9, 80.7 (q, J = 2.4 Hz), 62.2, 44.9. Rf: 0.51 (heptane/CH2Cl2, 1:1).
rac-(3R,5S)-3-(1H-Indol-2-yl)-2-phenyl-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (trans-4o). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 8.50 (bs, 1 H), 7.57−7.47 (m, 3 H), 7.32 (dt, J = 8.2, 0.9 Hz, 1
H), 7.06−7.03 (m, 1 H), 6.98−6.90 (m, 2 H), 6.86−6.82 (m, 2 H), 6.40
(d, J = 2.1 Hz, 1 H), 5.84 (dd, J = 8.3, 4.0 Hz, 1 H), 4.28 (dd, J = 9.4, 5.7
Hz, 1 H), 2.82 (dt, J = 13.7, 8.9 Hz, 1 H), 2.16−2.09 (m, 1 H). 13C
NMR [126 MHz, δ (ppm), CDCl3]: 148.5, 134.4, 132.7, 129.0, 128.6,
122.6, 122.5, 120.6, 119.5, 116.2, 111.3, 100.5, 82.1 (q, J = 2.4 Hz),
59.8, 44.6. Rf: 0.42 (heptane/CH2Cl2, 1:1).
3-(1H-Indol-2-yl)-2-phenyl-4-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (7o). 1H NMR [500 MHz, δ (ppm), CDCl3]: 7.64−7.59
(m, 2 H), 7.38−6.97 (m, 16 H), 6.59−6.55 (m, 2 H), 5.25 (d, J = 8.2
Hz, 1 H), 4.94 (d, J = 4.4 Hz, 1 H), 4.67−4.61 (m, 1 H), 4.61−4.56 (m,
1 H), 4.31 (q, J = 7.6 Hz, 1 H), 4.25−4.18 (m, 2 H), 4.11 (dd, J = 9.3,
6.2 Hz, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 149.3, 148.9,
135.9, 135.7, 135.5, 132.8, 129.2, 129.2, 128.5, 127.9, 123.4, 123.2,
122.7, 122.5, 120.8, 120.6, 120.3, 115.1, 115.0, 111.3, 111.2, 103.1,
100.6, 73.2, 72.7, 70.1, 65.6, 52.4, 48.1.
2-Phenyl-3-(1H-pyrrol-2-yl)-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (4p). According to the general procedure, the reaction of
nitrone 6p (44 mg, 0.234 mmol) and alkene 2 in a 1.5 mL PTFE high-
pressure tube aﬀorded a mixture of isoxazolidines cis- and trans-4p and
7p (33 mg, 0.105 mmol, 45%) as a brown oil, after column
chromatography (heptane/CH2Cl2, 4:1 → CH2Cl2/MeOH, 10:1).
FTIR [ν̅ (cm−1)]: 3421, 2960, 1597, 1489, 1154, 1109, 1082, 1029, 756,
722. HRMS (EI) m/z: [M+•] calcd for C14H13F3N2OS 314.0701, found
314.0706. Rf (unassigned mixture): 0.46, 0.30, 0.24, 0.20 (heptane/
CH2Cl2, 1:1). Total yield: 45%.
rac-(3R,5R)-2-Phenyl-3-(1H-pyrrol-2-yl)-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (cis-4p). 1H NMR [400 MHz, δ (ppm),
CDCl3]: 8.65 (bs, 1 H), 7.28−7.22 (m, 2 H), 7.08−6.98 (m, 3 H),
6.81−6.77 (m, 1 H), 6.21−6.18 (m, 1 H), 6.15−6.12 (m, 1 H), 6.03
(dd, J = 8.3, 3.6 Hz, 1 H), 4.62 (dd, J = 8.9, 5.6 Hz, 1 H), 3.34−3.17 (m,
1 H), 2.48−2.36 (m, 1 H). 13C NMR [101 MHz, δ (ppm), CDCl3]: δ
148.9, 130.0 (q, J = 307.9 Hz), 129.0, 128.8, 123.8, 116.8, 115.2, 109.1,
106.7, 80.7 (q, J = 2.3 Hz), 62.5, 44.6.
rac-(3R,5S)-2-Phenyl-3-(1H-pyrrol-2-yl)-5-[(triﬂuoromethyl)-
sulfanyl]isoxazolidine (trans-4p). 1H NMR [500 MHz, δ (ppm),
CDCl3]: 8.57 (bs, 1 H), 7.31−6.66 (m, 7 H), 6.27−6.15 (m, 1 H), 5.97
(t, J = 6.4 Hz, 1 H), 5.07 (dd, J = 7.0, 4.4 Hz, 1 H), 3.00 (ddd, J = 12.2,
7.1, 4.4 Hz, 1 H), 2.68 (dt, J = 13.1, 6.4 Hz, 1 H). 13C NMR [101 MHz,
δ (ppm), CDCl3]: 150.0, 129.9, 128.9, 123.8, 118.0, 115.8, 107.2, 106.3,
82.1, 62.7, 43.2. The carbon signal of SCF3 was not observed.
2-Phenyl-3-(1H-pyrrol-2-yl)-4-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (7p). 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.65 (bs, 1
H), 7.30−7.23 (m, 2 H), 7.06−6.99 (m, 3 H), 6.81−6.77 (m, 1 H),
6.27−6.19 (m, 1 H), 6.19 (m, 1 H), 5.11 (d, J = 7.8 Hz, 1 H), 4.66−4.55
(m, 1 H), 4.22 (q, J = 7.5 Hz, 1 H), 4.15 (dd, J = 8.6, 6.8 Hz, 1 H). 13C
NMR [101 MHz, δ (ppm), CDCl3]: 149.2, 129.3, 126.0, 123.4, 118.8,
115.2, 109.0, 108.8, 73.5, 65.3, 48.7 (q, J = 1.3 Hz). The carbon signal of
SCF3 was not observed.
2-Phenyl-3-(1H-pyrrol-2-yl)-4-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (7p). 1H NMR [500 MHz, δ (ppm), CDCl3]: 8.57 (bs, 1
H), 7.31−6.66 (m, 7 H), 6.27−6.15 (m, 1 H), 4.82 (d, J = 4.2 Hz, 1 H),
4.65−4.50 (m, 2 H), 4.26−4.10 (m, 1 H). 13C NMR [101 MHz, δ
(ppm), CDCl3]: 149.6, 129.4, 126.0, 124.1, 118.1, 115.2, 109.1, 108.7,
70.3, 65.3, 48.7. The carbon signal of SCF3 was not observed.
3-(Furan-2-yl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine
(4q). According to the general procedure, the reaction of nitrone 6q
(44 mg, 0.234 mmol) in a 1.5 mL PTFE high-pressure tube aﬀorded
isoxazolidine cis-4q (33.2 mg, 0.105 mmol, 45%) as an oﬀ white solid
and isoxazolidines trans-4q and 7q (24.7 mg, 0.078 mmol, 34%) as a
yellow oil, after column chromatography (heptane/CH2Cl2, 23:2 →
heptane/CH2Cl2, 0:1). Total yield: 79%.
rac-(3R,5R)-3-(Furan-2-yl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (cis-4q). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.45
(dd, J = 1.8, 0.9 Hz, 1 H), 7.31−7.22 (m, 2 H), 7.10−6.98 (m, 3 H),
6.37 (dd, J = 3.2, 1.8 Hz, 1 H), 6.35 (d, J = 3.2 Hz, 1 H), 6.00 (dd, J =
8.1, 4.5 Hz, 1 H), 4.50 (dd, J = 8.8, 6.5 Hz, 1 H), 3.23 (dddq, J = 13.5,
8.8, 8.1, 0.9 Hz, 1 H), 2.63 (ddd, J = 13.5, 6.5, 4.5 Hz, 1 H). 13C NMR
[101 MHz, δ (ppm), CDCl3]: 151.0, 148.7, 143.0, 130.2 (q, J = 307.7
Hz), 128.9, 124.2, 117.5, 110.8, 109.0, 80.5 (q, J = 2.6 Hz), 63.0, 42.4
(q, J = 1.2 Hz). FTIR [ν̅ (cm−1)]: 2922, 1489, 1453, 1254, 1106, 1037,
936, 743, 680. HRMS (EI) m/z: [M+•] calcd for C14H12F3NO2S
315.0541, found 315.0538. Rf: 0.48 (heptane/CH2Cl2, 7:3).
rac-(3R,5S)-3-(Furan-2-yl)-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine (trans-4q). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.37
(dd, J = 1.8, 0.9 Hz, 1 H), 7.27−7.22 (m, 2 H), 7.09−7.05 (m, 2 H),
6.98 (tt, J = 7.3, 1.2 Hz, 1 H), 6.30 (dd, J = 3.3, 1.8 Hz, 1 H), 6.26 (dt, J
= 3.3, 0.8, 1 H), 6.11 (dd, J = 7.4, 5.2 Hz, 1 H), 5.00 (dd, J = 7.7, 4.3, 1
H), 3.17 (dddq, J = 13.7, 7.4, 4.3, 0.8, 1 H), 2.77−2.67 (m, 1 H). 13C
NMR [101 MHz, δ (ppm), CDCl3]: 151.6, 149.2, 142.8, 130.0 (q, J =
307.7 Hz), 128.8, 123.0, 116.2, 110.6, 108.4, 81.8 (q, J = 2.5 Hz), 61.6,
41.6 (q, J = 1.2 Hz). FTIR [ν ̅ (cm−1)]: 2872, 1599, 1490, 1262, 1118,
1046, 757, 694. HRMS (EI) m/z: [M+•] calcd for C14H12F3NO2S
315.0541, found 315.0545. Rf: 0.39 (heptane/CH2Cl2, 7:3).
N-Benzyl-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]isoxazolidine-3-
carboxamide (4r). According to the general procedure, the reaction of
nitrone 6r (25 mg, 0.098 mmol) and alkene 2 in a 1 mL PTFE high-
pressure tube aﬀorded isoxazolidine cis-4r (3.2 mg, 0.0084 mmol, 9%;
used for NMR characterization) as a white solid and a mixture of
isoxazolidines cis- and trans-4r (16.1 mg, 0.042 mmol, 51%) as a yellow-
white solid, after column chromatography (heptane/CH2Cl2, 17:3 →
CH2Cl2/MeOH, 24:1). FTIR [ν ̅ (cm−1)]: 3385, 3309 2930, 1668,
1597, 1454, 1161, 1029, 697. HRMS (EI) m/z: [M+•] calcd for
C18H17F3N2O2S 382.0963, found 382.0964. Total yield: 60%.
rac-(3R,5R)-N-Benzyl-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine-3-carboxamide (cis-4r). 1H NMR [400 MHz, δ (ppm),
CDCl3]: 7.59−7.52 (m, 1 H), 7.37−7.27 (m, 7 H), 7.11−7.03 (m, 1
H), 7.02−6.97 (m, 2 H), 5.88 (dd, J = 8.1, 4.7 Hz, 1 H), 4.56 (dd, J =
14.8, 6.1 Hz, 1 H), 4.49 (dd, J = 14.8, 5.9 Hz, 1 H), 4.31 (dd, J = 9.6, 3.5
Hz, 1 H), 3.19−3.07 (m, 1 H), 2.75−2.65 (m, 1 H). 13C NMR [101
MHz, δ (ppm), CDCl3]: 169.7, 148.8, 137.6, 129.6 (q, J = 308.1 Hz),
129.5, 128.9, 127.9, 127.8, 123.9, 115.1, 80.3 (q, J = 2.5 Hz), 67.6, 43.7,
39.4.
rac-(3R,5S)-N-Benzyl-2-phenyl-5-[(triﬂuoromethyl)sulfanyl]-
isoxazolidine-3-carboxamide (trans-4r). 1H NMR [500 MHz, δ
(ppm), CDCl3]: 7.52−7.43 (m, 1 H), 7.36−7.23 (m, 7 H), 7.11−7.02
(m, 3 H), 5.91 (t, J = 6.8 Hz, 1 H), 4.54−4.49 (m, 2 H), 4.46 (dd, J =
15.0, 5.6 Hz, 1 H), 3.29 (ddd, J = 13.5, 7.3, 3.9 Hz, 1 H), 2.62 (ddd, J =
13.9, 8.1, 6.2 Hz, 1 H). 13C NMR [126 MHz, δ (ppm), CDCl3]: 169.1,
149.4, 137.6, 129.6 (q, J = 308.1 Hz), 129.0, 128.8, 127.7, 127.6, 123.6,
115.1, 82.3 (q, J = 2.5 Hz), 67.1, 43.5, 39.0.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.joc.7b02639.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.7b02639
J. Org. Chem. 2018, 83, 1779−1789
1788
Computational details, ASA and EDA of 6m and 6p, and
Cartesian coordinates (PDF)







Trevor A. Hamlin: 0000-0002-5128-1004
F. Matthias Bickelhaupt: 0000-0003-4655-7747
Floris P. J. T. Rutjes: 0000-0003-1538-3852
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
This work has been supported by the FP7Marie Curie Actions
of the European Commission via the ITN ECHONET Network
(MCITN-2012-316379) and NWO via the Planetary and
Exoplanetary Science program (PEPSci) and the Dutch
Astrochemistry Network (DAN). We thank Dr. Paul B. White
for his help in the assignment of the diastereo- and regioisomers,
and Birgit Kuhn (Bayer AG) for the helpful discussions.
■ REFERENCES
(1) (a) Xu, X. H.; Matsuzaki, K.; Shibata, N. Chem. Rev. 2015, 115,
731−764. (b) Liu, J.; Chu, L.; Qing, F. L. Org. Lett. 2013, 15, 894−897.
(c) Yang, Y. D.; Azuma, A.; Tokunaga, E.; Yamasaki, M.; Shiro, M.;
Shibata, N. J. Am. Chem. Soc. 2013, 135, 8782−8785. (d) Zhang, C. P.;
Vicic, D. A. J. Am. Chem. Soc. 2012, 134, 183−185. (e) Hansch, C.; Leo,
A.; Unger, S. H.; Kim, K. H.; Nikaitani, D.; Lien, E. J. J. Med. Chem.
1973, 16, 1207−1216.
(2) Aswapokee, N.; Neu, H. C. Antimicrob. Agents Chemother. 1979,
15, 444−446.
(3) Pommier, P.; Keita, A.; Wessel-Robert, S.; Dellac, B.; Mundt, H.
C. Rev. Med. Vet. 2003, 154, 41.
(4) Yagupolskii, L. M.; Maletina, I. I.; Petko, K. I.; Fedyuk, D. V.;
Handrock, R.; Shavaran, S. S.; Klebanov, B. M.; Herzig, S. J. Fluorine
Chem. 2001, 109, 87−94.
(5) (a) Jiang, L.; Qian, J.; Yi, W.; Lu, G.; Cai, C.; Zhang, W. Angew.
Chem., Int. Ed. 2015, 54, 14965−14969. (b) Shao, X.; Wang, X.; Yang,
T.; Lu, L.; Shen, Q. Angew. Chem., Int. Ed. 2013, 52, 3457−3460.
(c) Weng, Z.; He, W.; Chen, C.; Lee, R.; Tan, D.; Lai, Z.; Kong, D.;
Yuan, Y.; Huang, K. W. Angew. Chem., Int. Ed. 2013, 52, 1548−1552.
(d) Yang, Y. D.; Azuma, A.; Tokunaga, E.; Yamasaki, M.; Shiro, M.;
Shibata, N. J. Am. Chem. Soc. 2013, 135, 8782−8785. (e) Zhang, C. P.;
Vicic, D. A. J. Am. Chem. Soc. 2012, 134, 183−185. (f) Teverovskiy, G.;
Surry, D. S.; Buchwald, S. L. Angew. Chem., Int. Ed. 2011, 50, 7312−
7314.
(6) (a) Kieltsch, I.; Eisenberger, P.; Togni, A. Angew. Chem., Int. Ed.
2007, 46, 754−757. (b) Pooput, C.; Dolbier, W. R., Jr.; Med́ebielle, M.
J. Org. Chem. 2006, 71, 3564−3568. (c) Pooput, C.; Med́ebielle, M.;
Dolbier, W. R., Jr Org. Lett. 2004, 6, 301−303. (d) Billard, T.; Large, S.;
Langlois, B. R. Tetrahedron Lett. 1997, 38, 65−68.
(7) Harris, J. F., Jr J. Org. Chem. 1967, 32, 2063−2074.
(8) Haas, A.; Hinsken, W. J. Fluorine Chem. 1985, 28, 303−317.
(9) For examples of 1,3-dipolar cycloaddition reactions between
alkenes and nitrones, see: (a) Chakraborty, B.; Luitel, G. P. Tetrahedron
Lett. 2013, 54, 765−770. (b) Gothelf, K. V.; Jørgensen, K. A. Chem.
Commun. 2000, 1449−1458. (c) Simonsen, K. B.; Bayoń, P.; Hazell, R.
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